Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
PJ Riekkinen
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Living Beings
Disorders
Procedures
Anatomy
Chemicals & Drugs
Physiology
Concepts & Ideas
Sign-in to see full Profile
Network (preview)
178
Sirviö, Jouni
124
Soininen, Hilkka
80
Riekkinen, Mervi
53
Helkala, Eeva-Liisa
49
Jäkälä, Pekka
43
Partanen, Juhani
42
Miettinen, Riitta
40
Pitkänen, Asla
38
Koivisto, Esa
33
Ylinen, Aarne
32
Valjakka, Antti
32
Laakso, Markku
29
Jolkkonen, Jukka
29
Sivenius, Juhani
26
Halonen, Toivo
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of PJ Riekkinen (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2001: Björklund M; Siverina I; Heikkinen T; Tanila H; Sallinen J; Scheinin M; Riekkinen P
Spatial working memory improvement by an alpha2-adrenoceptor agonist dexmedetomidine is not mediated through alpha2C-adrenoceptor.
Progress in neuro-psychopharmacology & biological psychiatry 2001;25(8):1539-54.
-
2001: Ihalainen J A; Tanila H; Scheinin M; Riekkinen P
alpha(2C)-Adrenoceptors modulate the effect of methylphenidate on response rate and discrimination accuracy in an operant test.
Brain research bulletin 2001;54(5):553-7.
-
2000: Laakso M P; Lehtovirta M; Partanen K; Riekkinen P J; Soininen H
Hippocampus in Alzheimer's disease: a 3-year follow-up MRI study.
Biological psychiatry 2000;47(6):557-61.
-
2000: Aura J; Riekkinen P
Pre-training blocks the improving effect of tetrahydroaminoacridine and D-cycloserine on spatial navigation performance in aged rats.
European journal of pharmacology 2000;390(3):313-8.
-
2000: Lehtovirta M; Partanen J; Könönen M; Hiltunen J; Helisalmi S; Hartikainen P; Riekkinen P; Soininen H
A longitudinal quantitative EEG study of Alzheimer's disease: relation to apolipoprotein E polymorphism.
Dementia and geriatric cognitive disorders 2000;11(1):29-35.
-
2000: Puoliväli J; Miettinen R; Pradier L; Riekkinen P
Apolipoprotein E-deficient mice are not more susceptible to the biochemical and memory deficits induced by nucleus basalis lesion.
Neuroscience 2000;96(2):291-7.
-
2000: Björklund M; Sirviö J; Riekkinen M; Sallinen J; Scheinin M; Riekkinen P
Overexpression of alpha2C-adrenoceptors impairs water maze navigation.
Neuroscience 2000;95(2):481-7.
-
2000: Puoliväli J; Pradier L; Riekkinen P
Impaired recovery of noradrenaline levels in apolipoprotein E-deficient mice after N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine lesion.
Neuroscience 2000;95(2):353-8.
-
1999: Ihalainen J A; Riekkinen P; Feenstra M G
Comparison of dopamine and noradrenaline release in mouse prefrontal cortex, striatum and hippocampus using microdialysis.
Neuroscience letters 1999;277(2):71-4.
-
1999: Aikiä M; Kälviäinen R; Mervaala E; Riekkinen P J
Predictors of seizure outcome in newly diagnosed partial epilepsy: memory performance as a prognostic factor.
Epilepsy research 1999;37(2):159-67.
-
1999: Ikonen S; Riekkinen P
Effects of apamin on memory processing of hippocampal-lesioned mice.
European journal of pharmacology 1999;382(3):151-6.
-
1999: Riekkinen M; Riekkinen P
Alpha2-adrenergic agonist clonidine for improving spatial working memory in Parkinson's disease.
Journal of clinical psychopharmacology 1999;19(5):444-9.
-
1999: Jäkälä P; Riekkinen M; Sirviö J; Koivisto E; Riekkinen P
Clonidine, but not guanfacine, impairs choice reaction time performance in young healthy volunteers.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1999;21(4):495-502.
-
1999: Wilson I A; Puoliväli J; Heikkinen T; Riekkinen P
Estrogen and NMDA receptor antagonism: effects upon reference and working memory.
European journal of pharmacology 1999;381(2-3):93-9.
-
1999: Kälviäinen R; Nousiainen I; Mäntyjärvi M; Nikoskelainen E; Partanen J; Partanen K; Riekkinen P
Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field defects.
Neurology 1999;53(5):922-6.
-
1999: Sivenius J; Cunha L; Diener H C; Forbes C; Laakso M; Lowenthal A; Smets P; Riekkinen P
Antiplatelet treatment does not reduce the severity of subsequent stroke. European Stroke Prevention Study 2 Working Group.
Neurology 1999;53(4):825-9.
-
1999: Hiltunen M; Mannermaa A; Koivisto A M; Lehtovirta M; Helisalmi S; Ryynänen M; Riekkinen P; Soininen H
Linkage disequilibrium in the 13q12 region in Finnish late onset Alzheimer's disease patients.
European journal of human genetics : EJHG 1999;7(6):652-8.
-
1999: Puoliväli J; Pradier L; Riekkinen P
Moderate cortical EEG changes in apolipoprotein E-deficient mice during ageing and scopolamine treatment but not after nucleus basalis lesion.
Psychopharmacology 1999;145(4):386-92.
-
1999: Vanhanen M; Kuusisto J; Koivisto K; Mykkänen L; Helkala E L; Hänninen T; Riekkinen P; Soininen H; Laakso M
Type-2 diabetes and cognitive function in a non-demented population.
Acta neurologica Scandinavica 1999;100(2):97-101.
-
1999: Overmyer M; Helisalmi S; Soininen H; Laakso M; Riekkinen P; Alafuzoff I
Astrogliosis and the ApoE genotype. an immunohistochemical study of postmortem human brain tissue.
Dementia and geriatric cognitive disorders 1999;10(4):252-7.
-
1999: Ikonen S; Schmidt B H; Riekkinen P
Characterization of learning and memory behaviors and the effects of metrifonate in the C57BL strain of mice.
European journal of pharmacology 1999;372(2):117-26.
-
1999: Ylinen A; Salmenperä T; Mumford J P; Riekkinen P J
Long-term treatment with vigabatrin - 10 years of clinical experience.
Seizure : the journal of the British Epilepsy Association 1999;8(3):181-3.
-
1999: Jäkälä P; Riekkinen M; Sirviö J; Koivisto E; Kejonen K; Vanhanen M; Riekkinen P
Guanfacine, but not clonidine, improves planning and working memory performance in humans.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1999;20(5):460-70.
-
1999: Rissanen A; Puoliväli J; van Groen T; Riekkinen P
In mice tonic estrogen replacement therapy improves non-spatial and spatial memory in a water maze task.
Neuroreport 1999;10(6):1369-72.
-
1999: Overmyer M; Helisalmi S; Soininen H; Laakso M; Riekkinen P; Alafuzoff I
Reactive microglia in aging and dementia: an immunohistochemical study of postmortem human brain tissue.
Acta neuropathologica 1999;97(4):383-92.
-
1999: Riekkinen P; Riekkinen M
THA improves word priming and clonidine enhances fluency and working memory in Alzheimer's disease.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1999;20(4):357-64.
-
1999: Aura J; Riekkinen P
Blockade of NMDA receptors located at the dorsomedial prefrontal cortex impairs spatial working memory in rats.
Neuroreport 1999;10(2):243-8.
-
1999: Tanila H; Mustonen K; Sallinen J; Scheinin M; Riekkinen P
Role of alpha2C-adrenoceptor subtype in spatial working memory as revealed by mice with targeted disruption of the alpha2C-adrenoceptor gene.
The European journal of neuroscience 1999;11(2):599-603.
-
1999: Jäkälä P; Sirviö J; Riekkinen M; Koivisto E; Kejonen K; Vanhanen M; Riekkinen P
Guanfacine and clonidine, alpha 2-agonists, improve paired associates learning, but not delayed matching to sample, in humans.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1999;20(2):119-30.
-
1999: Riekkinen P; Ikonen S; Aura J; Riekkinen M
Tetrahydroaminoacridine and D-cycloserine fail to alleviate the water maze spatial navigation defect induced by hippocampal inactivation.
European journal of pharmacology 1999;366(1):13-8.
-
1999: Sivenius J; Cunha L; Diener H C; Forbes C; Laakso M; Lowenthal A; Smets P; Riekkinen P
Second European Stroke Prevention Study: antiplatelet therapy is effective regardless of age. ESPS2 Working Group.
Acta neurologica Scandinavica 1999;99(1):54-60.
-
1999: Riekkinen M; Jäkälä P; Kejonen K; Riekkinen P
The alpha2 agonist, clonidine, improves spatial working performance in Parkinson's disease.
Neuroscience 1999;92(3):983-9.
-
1999: Björklund M; Sirviö J; Sallinen J; Scheinin M; Kobilka B K; Riekkinen P
Alpha2C-adrenoceptor overexpression disrupts execution of spatial and non-spatial search patterns.
Neuroscience 1999;88(4):1187-98.
-
1998: Riekkinen P; Schmidt B H; van der Staay F J
Animal models in the development of symptomatic and preventive drug therapies for Alzheimer's disease.
Annals of medicine 1998;30(6):566-76.
-
1998: Puoliväli J; Jäkälä P; Koivisto E; Riekkinen P
Oxotremorine suppresses thalamocortical oscillations via thalamic muscarinic acetylcholine receptors.
Psychopharmacology 1998;140(3):285-92.
-
1998: Riekkinen P; Ikonen S; Riekkinen M
D-cycloserine, a partial NMDA receptor-associated glycine-B site agonist, enhances reversal learning, but a cholinesterase inhibitor and nicotine has no effect.
Neuroreport 1998;9(16):3647-51.
-
1998: Miettinen R; Kotti T; Tuunanen J; Toppinen A; Riekkinen P; Halonen T
Hippocampal damage after injection of kainic acid into the rat entorhinal cortex.
Brain research 1998;813(1):9-17.
-
1998: Niittykoski M; Lappalainen R; Jolkkonen J; Haapalinna A; Riekkinen P; Sirviö J
Systemic administration of atipamezole, a selective antagonist of alpha-2 adrenoceptors, facilitates behavioural activity but does not influence short-term or long-term memory in trimethyltin-intoxicated and control rats.
Neuroscience and biobehavioral reviews 1998;22(6):735-50.
-
1998: Kraszpulski M; Soininen H; Riekkinen P; Alafuzoff I
Pitfalls in the quantitative estimation of beta-amyloid immunoreactivity in human brain tissue.
Histochemistry and cell biology 1998;110(4):439-45.
-
1998: Björklund M; Sirviö J; Puoliväli J; Sallinen J; Jäkälä P; Scheinin M; Kobilka B K; Riekkinen P
Alpha2C-adrenoceptor-overexpressing mice are impaired in executing nonspatial and spatial escape strategies.
Molecular pharmacology 1998;54(3):569-76.
-
1998: Juottonen K; Lehtovirta M; Helisalmi S; Riekkinen P J; Soininen H
Major decrease in the volume of the entorhinal cortex in patients with Alzheimer's disease carrying the apolipoprotein E epsilon4 allele.
Journal of neurology, neurosurgery, and psychiatry 1998;65(3):322-7.
-
1998: Puranen J; Laakso M; Riekkinen P J; Sivenius J
Efficacy of antiplatelet treatment in hypertensive patients with TIA or stroke.
Journal of cardiovascular pharmacology 1998;32(2):291-4.
-
1998: Tapiola T; Lehtovirta M; Pirttilä T; Alafuzoff I; Riekkinen P; Soininen H
Increased aspartate aminotransferase activity in cerebrospinal fluid and Alzheimer's disease.
Lancet 1998;352(9124):287.
-
1998: Hiltunen M; Mannermaa A; Helisalmi S; Koivisto A; Lehtovirta M; Ryynänen M; Riekkinen P; Soininen H
Butyrylcholinesterase K variant and apolipoprotein E4 genes do not act in synergy in Finnish late-onset Alzheimer's disease patients.
Neuroscience letters 1998;250(1):69-71.
-
1998: Pirttilä T; Koivisto K; Mehta P D; Reinikainen K; Kim K S; Kilkku O; Heinonen E; Soininen H; Riekkinen P; Wisniewski H M
Longitudinal study of cerebrospinal fluid amyloid proteins and apolipoprotein E in patients with probable Alzheimer's disease.
Neuroscience letters 1998;249(1):21-4.
-
1998: Puoliväli J; Jäkälä P; Koivisto E; Riekkinen P
Muscarinic M1 and M2 receptor subtype selective drugs modulate neocortical EEG via thalamus.
Neuroreport 1998;9(8):1685-9.
-
1998: Riekkinen P; Ikonen S; Riekkinen M
Tetrahydroaminoacridine, a cholinesterase inhibitor, and D-cycloserine, a partial NMDA receptor-associated glycine site agonist, enhances acquisition of spatial navigation.
Neuroreport 1998;9(7):1633-7.
-
1998: Riekkinen P; Kejonen K; Laakso M P; Soininen H; Partanen K; Riekkinen M
Hippocampal atrophy is related to impaired memory, but not frontal functions in non-demented Parkinson's disease patients.
Neuroreport 1998;9(7):1507-11.
-
1998: Kälviäinen R; Salmenperä T; Partanen K; Vainio P; Riekkinen P; Pitkänen A
Recurrent seizures may cause hippocampal damage in temporal lobe epilepsy.
Neurology 1998;50(5):1377-82.
-
1998: Riekkinen M; Kejonen K; Jäkälä P; Soininen H; Riekkinen P
Reduction of noradrenaline impairs attention and dopamine depletion slows responses in Parkinson's disease.
The European journal of neuroscience 1998;10(4):1429-35.
-
1998: Ikonen S; Schmidt B; Riekkinen P
Apamin improves spatial navigation in medial septal-lesioned mice.
European journal of pharmacology 1998;347(1):13-21.
-
1998: Tanila H; Björklund M; Riekkinen P
Cognitive changes in mice following moderate MPTP exposure.
Brain research bulletin 1998;45(6):577-82.
-
1998: Vanhanen M; Koivisto K; Kuusisto J; Mykkänen L; Helkala E L; Hänninen T; Riekkinen P; Soininen H; Laakso M
Cognitive function in an elderly population with persistent impaired glucose tolerance.
Diabetes care 1998;21(3):398-402.
-
1998: Riekkinen M; Soininen H; Riekkinen P; Kuikka J; Laakso M; Helkala E L; Partanen J; Riekkinen P
Tetrahydroaminoacridine improves the recency effect in Alzheimer's disease.
Neuroscience 1998;83(2):471-9.
-
1998: Riekkinen M; Soininen H; Riekkinen P; Kuikka J; Laakso M; Helkala E L; Partanen J; Riekkinen P
Tetrahydroaminoacridine improves the recency effect in Alzheimer's disease.
Neuroscience 1998;83(2):471-9.
-
1998: Puranen J; Laakso M; Riekkinen P; Sivenius J
Risk factors and antiplatelet therapy in TIA and stroke patients.
Journal of the neurological sciences 1998;154(2):200-4.
-
1998: Puumala T; Greijus S; Narinen K; Haapalinna A; Riekkinen P; Sirviö J
Stimulation of alpha-1 adrenergic receptors facilitates spatial learning in rats.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1998;8(1):17-26.
-
1998: Laakso M P; Soininen H; Partanen K; Lehtovirta M; Hallikainen M; Hänninen T; Helkala E L; Vainio P; Riekkinen P J
MRI of the hippocampus in Alzheimer's disease: sensitivity, specificity, and analysis of the incorrectly classified subjects.
Neurobiology of aging 1998;19(1):23-31.
-
1998: Aura J; Riekkinen M; Riekkinen P
Tetrahydroaminoacridine and D-cycloserine stimulate acquisition of water maze spatial navigation in aged rats.
European journal of pharmacology 1998;342(1):15-20.
-
1998: Tapiola T; Lehtovirta M; Ramberg J; Helisalmi S; Linnaranta K; Riekkinen P; Soininen H
CSF tau is related to apolipoprotein E genotype in early Alzheimer's disease.
Neurology 1998;50(1):169-74.
-
1998: Ruotsalainen S; MacDonald E; Koivisto E; Stefanski R; Haapalinna A; Riekkinen P; Sirviö J
5-HT1A receptor agonist (8-OH-DPAT) and 5-HT2 receptor agonist (DOI) disrupt the non-cognitive performance of rats in a working memory task.
Journal of psychopharmacology (Oxford, England) 1998;12(2):177-85.
-
1997: Tapiola T; Overmyer M; Lehtovirta M; Helisalmi S; Ramberg J; Alafuzoff I; Riekkinen P; Soininen H
The level of cerebrospinal fluid tau correlates with neurofibrillary tangles in Alzheimer's disease.
Neuroreport 1997;8(18):3961-3.
-
1997: Riekkinen M; Schmidt B H; Riekkinen P
Subchronic treatment increases the duration of the cognitive enhancement induced by metrifonate.
European journal of pharmacology 1997;338(2):105-10.
-
1997: Kuusisto J; Koivisto K; Mykkänen L; Helkala E L; Vanhanen M; Hänninen T; Kervinen K; Kesäniemi Y A; Riekkinen P J; Laakso M
Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study.
BMJ (Clinical research ed.) 1997;315(7115):1045-9.
-
1997: Riekkinen P; Pääkkönen A; Karhu J; Partanen J; Soininen H; Laakso M; Riekkine P
THA disrupts mismatch negativity in Alzheimer disease.
Psychopharmacology 1997;133(2):203-6.
-
1997: Kotti T; Halonen T; Sirviö J; Riekkinen P; Miettinen R
Comparison of NADPH diaphorase histochemistry, somatostatin immunohistochemistry, and silver impregnation in detecting structural and functional impairment in experimental status epilepticus.
Neuroscience 1997;80(1):105-17.
-
1997: Aura J; Sirviö J; Riekkinen P
Methoctramine moderately improves memory but pirenzepine disrupts performance in delayed non-matching to position test.
European journal of pharmacology 1997;333(2-3):129-34.
-
1997: Jäkälä P; Puolivali J; Björklund M; Koivisto E; Riekkinen P
Activation of acetylcholine receptors and 5-HT2 receptors have additive effects in the suppression of neocortical high-voltage spindles in aged rats.
Psychopharmacology 1997;132(3):270-80.
-
1997: Kuhmonen J; Pokorný J; Miettinen R; Haapalinna A; Jolkkonen J; Riekkinen P; Sivenius J
Neuroprotective effects of dexmedetomidine in the gerbil hippocampus after transient global ischemia.
Anesthesiology 1997;87(2):371-7.
-
1997: Helisalmi S; Mannermaa A; Lehtovirta M; Ryynänen M; Riekkinen P; Soininen H
No association between alpha1-antichymotrypsin polymorphism, apolipoprotein E and patients with late-onset Alzheimer's disease.
Neuroscience letters 1997;231(1):56-8.
-
1997: Kotti T; Riekkinen P J; Miettinen R
Characterization of target cells for aberrant mossy fiber collaterals in the dentate gyrus of epileptic rat.
Experimental neurology 1997;146(2):323-30.
-
1997: Kälviäinen R; Salmenperä T; Partanen K; Vainio P; Riekkinen P; Pitkänen A
MRI volumetry and T2 relaxometry of the amygdala in newly diagnosed and chronic temporal lobe epilepsy.
Epilepsy research 1997;28(1):39-50.
-
1997: Riekkinen P; Riekkinen M; Soininen H; Kuikka J; Laakso M; Riekkinen P
Frontal dysfunction blocks the therapeutic effect of THA on attention in Alzheimer's disease.
Neuroreport 1997;8(8):1845-9.
-
1997: Riekkinen P; Riekkinen M; Soininen H; Kuikka J; Laakso M; Riekkinen P
Frontal dysfunction blocks the therapeutic effect of THA on attention in Alzheimer's disease.
Neuroreport 1997;8(8):1845-9.
-
1997: Riekkinen M; Kemppainen S; Riekkinen P
Effects of stimulation of alpha 1-adrenergic and NMDA/glycine-B receptors on learning defects in aged rats.
Psychopharmacology 1997;131(1):49-56.
-
1997: Ruotsalainen S; Sirviö J; Jäkälä P; Puumala T; MacDonald E; Riekkinen P
Differential effects of three 5-HT receptor antagonists on the performance of rats in attentional and working memory tasks.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1997;7(2):99-108.
-
1997: Vanhanen M; Koivisto K; Karjalainen L; Helkala E L; Laakso M; Soininen H; Riekkinen P
Risk for non-insulin-dependent diabetes in the normoglycaemic elderly is associated with impaired cognitive function.
Neuroreport 1997;8(6):1527-30.
-
1997: Ruotsalainen S; MacDonald E; Miettinen R; Puumala T; Riekkinen P; Sirviö J
Additive deficits in the choice accuracy of rats in the delayed non-matching to position task after cholinolytics and serotonergic lesions are non-mnemonic in nature.
Psychopharmacology 1997;130(4):303-12.
-
1997: Jäkälä P; Riekkinen P
Combined cholinergic and 5-HT2 receptor activation suppresses thalamocortical oscillations in aged rats.
Pharmacology, biochemistry, and behavior 1997;56(4):713-8.
-
1997: Puumala T; Riekkinen P; Sirviö J
Modulation of vigilance and behavioral activation by alpha-1 adrenoceptors in the rat.
Pharmacology, biochemistry, and behavior 1997;56(4):705-12.
-
1997: Riekkinen P; Schmidt B; Riekkinen M
Behavioral characterization of metrifonate-improved acquisition of spatial information in medial septum-lesioned rats.
European journal of pharmacology 1997;323(1):11-9.
-
1997: Riekkinen M; Schmidt B; Kuitunen J; Riekkinen P
Effects of combined chronic nimodipine and acute metrifonate treatment on spatial and avoidance behavior.
European journal of pharmacology 1997;322(1):1-9.
-
1997: Puurunen K; Sirviö J; Koistinaho J; Miettinen R; Haapalinna A; Riekkinen P; Sivenius J
Studies on the influence of enriched-environment housing combined with systemic administration of an alpha2-adrenergic antagonist on spatial learning and hyperactivity after global ischemia in rats.
Stroke; a journal of cerebral circulation 1997;28(3):623-31.
-
1997: Riekkinen M; Riekkinen P
Nicotine and D-cycloserine enhance acquisition of water maze spatial navigation in aged rats.
Neuroreport 1997;8(3):699-703.
-
1997: Riekkinen M; Riekkinen P
Dorsal hippocampal muscarinic acetylcholine and NMDA receptors disrupt water maze navigation.
Neuroreport 1997;8(3):645-8.
-
1997: Riekkinen P; Soininen H; Partanen J; Pääkkönen A; Helisalmi S; Riekkinen P
The ability of THA treatment to increase cortical alpha waves is related to apolipoprotein E genotype of Alzheimer disease patients.
Psychopharmacology 1997;129(3):285-8.
-
1997: Riekkinen P; Soininen H; Partanen J; Pääkkönen A; Helisalmi S; Riekkinen P
The ability of THA treatment to increase cortical alpha waves is related to apolipoprotein E genotype of Alzheimer disease patients.
Psychopharmacology 1997;129(3):285-8.
-
1997: Riekkinen P; Schmidt B; Jäkälä P; Koivisto E; Björklund M
Chronic nimodipine and acute metrifonate treatment decreases age-related cortical high voltage spindles in rats.
Psychopharmacology 1997;129(1):91-5.
-
1997: Pussinen R; Nieminen S; Koivisto E; Haapalinna A; Riekkinen P; Sirvio J
Enhancement of intermediate-term memory by an alpha-1 agonist or a partial agonist at the glycine site of the NMDA receptor.
Neurobiology of learning and memory 1997;67(1):69-74.
-
1997: Kälviäinen R; Partanen K; Aikiä M; Mervaala E; Vainio P; Riekkinen P J; Pitkänen A
MRI-based hippocampal volumetry and T2 relaxometry: correlation to verbal memory performance in newly diagnosed epilepsy patients with left-sided temporal lobe focus.
Neurology 1997;48(1):286-7.
-
1997: Hänninen T; Hallikainen M; Koivisto K; Partanen K; Laakso M P; Riekkinen P J; Soininen H
Decline of frontal lobe functions in subjects with age-associated memory impairment.
Neurology 1997;48(1):148-53.
-
1997: Helkala E L; Koivisto K; Hanninen T; Vanhanen M; Kuusisto J; Mykkanen L; Laakso M; Riekkinen P
Stability of age-associated memory impairment during a longitudinal population-based study.
Journal of the American Geriatrics Society 1997;45(1):120-2.
-
1997: Pirttilä T; Soininen H; Mehta P D; Heinonen O; Lehtimäki T; Bogdanovic N; Paljärvi L; Kim K S; Kosunen O; Winblad B; Riekkinen P; Wisniewski H M
Apolipoprotein E genotype and amyloid load in Alzheimer disease and control brains.
Neurobiology of aging 1997;18(1):121-7.
-
1997: Ruotsalainen S; Haapalinna A; Riekkinen P J; Sirviö J
Dexmedetomidine reduces response tendency, but not accuracy of rats in attention and short-term memory tasks.
Pharmacology, biochemistry, and behavior 1997;56(1):31-40.
-
1997: Riekkinen P
[Neurological research today]
Duodecim; lääketieteellinen aikakauskirja 1997;113(18):1721-6.
-
1997: Partanen J; Soininen H; Helkala E L; Könönen M; Kilpeläinen R; Riekkinen P
Relationship between EEG reactivity and neuropsychological tests in vascular dementia.
Journal of neural transmission (Vienna, Austria : 1996) 1997;104(8-9):905-12.
-
1997: Bodick N; Forette F; Hadler D; Harvey R J; Leber P; McKeith I G; Riekkinen P J; Rossor M N; Scheltens P; Shimohama S; Spiegel R; Tanaka S; Thal L J; Urata Y; Whitehouse P; Wilcock G
Protocols to demonstrate slowing of Alzheimer disease progression. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. The Disease Progression Sub-Group.
Alzheimer disease and associated disorders 1997;11 Suppl 3():50-3.
-
1997: Puumala T; Björklund M; Ruotsalainen S; Riekkinen M; Jäkälä P; Haapalinna A; Björk E; Riekkinen P; Sirviö J
Lack of relationship between thalamic oscillations and attention in rats: differential modulation by an alpha-2 antagonist.
Brain research bulletin 1997;43(2):163-71.
-
1996: Jäkälä P; Riekkinen M; Björklund M; Koivisto E; Schmidt B; Riekkinen P
Effects of combined nimodipine and metrifonate on rat cognition and cortical EEG.
European journal of pharmacology 1996;318(2-3):239-50.
-
1996: Helkala E L; Hänninen T; Hallikainen M; Könönen M; Laakso M P; Hartikainen P; Soininen H; Partanen J; Partanen K; Vainio P; Riekkinen P
Slow-wave activity in the spectral analysis of the electroencephalogram and volumes of hippocampus in subgroups of Alzheimer's disease patients.
Behavioral neuroscience 1996;110(6):1235-43.
-
1996: Jäkälä P; Björklund M; Koivisto E; Riekkinen P
The effects of cholinergic drugs on rat neocortical high-voltage spindles in ketanserin-treated rats.
European journal of pharmacology 1996;316(2-3):181-93.
-
1996: Vanhanen M; Karhu J; Koivisto K; Pääkkönen A; Partanen J; Laakso M; Riekkinen P
ERPs reveal deficits in automatic cerebral stimulus processing in patients with NIDDM.
Neuroreport 1996;7(15-17):2767-71.
-
1996: Kälviäinen R; Aikiä M; Mervaala E; Saukkonen A M; Pitkänen A; Riekkinen P J
Long-term cognitive and EEG effects of tiagabine in drug-resistant partial epilepsy.
Epilepsy research 1996;25(3):291-7.
-
1996: Kotti T; Tapiola T; Riekkinen P J; Miettinen R
The calretinin-containing mossy cells survive excitotoxic insult in the gerbil dentate gyrus. Comparison of excitotoxicity-induced neuropathological changes in the gerbil and rat.
The European journal of neuroscience 1996;8(11):2371-8.
-
1996: Partanen J; Soininen H; Könönen M; Kilpeläinen R; Helkala E L; Riekkinen P
EEG reactivity correlates with neuropsychological test scores in Down's syndrome.
Acta neurologica Scandinavica 1996;94(4):242-6.
-
1996: Puumala T; Ruotsalainen S; Jäkälä P; Koivisto E; Riekkinen P; Sirviö J
Behavioral and pharmacological studies on the validation of a new animal model for attention deficit hyperactivity disorder.
Neurobiology of learning and memory 1996;66(2):198-211.
-
1996: Reeben M; Arbatova J; Palgi J; Miettinen R; Halmekytö M; Alhonen L; Jänne J; Riekkinen P; Saarma M
Induced expression of neurotrophins in transgenic mice overexpressing ornithine decarboxylase and overproducing putrescine.
Journal of neuroscience research 1996;45(5):542-8.
-
1996: Puumala T; Sirviö J; Ruotsalainen S; Riekkinen P
Effects of St-587 and prazosin on water maze and passive avoidance performance of scopolamine-treated rats.
Pharmacology, biochemistry, and behavior 1996;55(1):107-15.
-
1996: Riekkinen P; Schmidt B; Stefanski R; Kuitunen J; Riekkinen M
Metrifonate improves spatial navigation and avoidance behavior in scopolamine-treated, medial septum-lesioned and aged rats.
European journal of pharmacology 1996;309(2):121-30.
-
1996: Riekkinen M; Aroviita L; Kivipelto M; Taskila K; Riekkinen P
Depletion of serotonin, dopamine and noradrenaline in aged rats decreases the therapeutic effect of nicotine, but not of tetrahydroaminoacridine.
European journal of pharmacology 1996;308(3):243-50.
-
1996: Laakso M P; Partanen K; Soininen H; Lehtovirta M; Hallikainen M; Hänninen T; Helkala E L; Vainio P; Riekkinen P J
MR T2 relaxometry in Alzheimer's disease and age-associated memory impairment.
Neurobiology of aging 1996;17(4):535-40.
-
1996: Lehtovirta M; Partanen J; Könönen M; Soininen H; Helisalmi S; Mannermaa A; Ryynänen M; Hartikainen P; Riekkinen P
Spectral analysis of EEG in Alzheimer's disease: relation to apolipoprotein E polymorphism.
Neurobiology of aging 1996;17(4):523-6.
-
1996: Soininen H S; Riekkinen P J
Apolipoprotein E, memory and Alzheimer's disease.
Trends in neurosciences 1996;19(6):224-8.
-
1996: Pitkänen A; Laakso M; Kälviäinen R; Partanen K; Vainio P; Lehtovirta M; Riekkinen P; Soininen H
Severity of hippocampal atrophy correlates with the prolongation of MRI T2 relaxation time in temporal lobe epilepsy but not in Alzheimer's disease.
Neurology 1996;46(6):1724-30.
-
1996: Lehtovirta M; Soininen H; Laakso M P; Partanen K; Helisalmi S; Mannermaa A; Ryynänen M; Kuikka J; Hartikainen P; Riekkinen P J
SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E epsilon 4 allele.
Journal of neurology, neurosurgery, and psychiatry 1996;60(6):644-9.
-
1996: Pirttilä T; Soininen H; Heinonen O; Lehtimäki T; Bogdanovic N; Paljärvi L; Kosunen O; Winblad B; Riekkinen P; Wisniewski H M; Mehta P D
Apolipoprotein E (apoE) levels in brains from Alzheimer disease patients and controls.
Brain research 1996;722(1-2):71-7.
-
1996: Hanninen T; Koivisto K; Reinikainen K J; Helkala E L; Soininen H; Mykkänen L; Laakso M; Riekkinen P J
Prevalence of ageing-associated cognitive decline in an elderly population.
Age and ageing 1996;25(3):201-5.
-
1996: Riekkinen P; Mettinger K L; Karukin M; Riekkinen M
Effects of Alzene and tacrine on water maze reference and working memory function in medial septal-lesioned rats.
Brain research 1996;714(1-2):118-24.
-
1996: Björklund M; Jäkälä P; Schmidt B; Riekkinen M; Koivisto E; Riekkinen P
An indirect cholinesterase inhibitor, metrifonate, increases neocortical EEG arousal in rats.
Neuroreport 1996;7(5):1097-101.
-
1996: Riekkinen M; Stefanski R; Kuitunen J; Riekkinen P
Effects of combined block of alpha 1-adrenoceptors and NMDA receptors on spatial and passive avoidance behavior in rats.
European journal of pharmacology 1996;300(1-2):9-16.
-
1996: Jäkälä P; Björklund M; Riekkinen P
Suppression of neocortical high-voltage spindles by nicotinic acetylcholine and 5-HT2 receptor stimulation.
European journal of pharmacology 1996;299(1-3):47-60.
-
1996: Laakso M P; Partanen K; Riekkinen P; Lehtovirta M; Helkala E L; Hallikainen M; Hanninen T; Vainio P; Soininen H
Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: An MRI study.
Neurology 1996;46(3):678-81.
-
1996: Helkala E L; Koivisto K; Hanninen T; Vanhanen M; Kervinen K; Kuusisto J; Mykkanen L; Kesaniemi Y A; Laakso M; Riekkinen P
Memory functions in human subjects with different apolipoprotein E phenotypes during a 3-year population-based follow-up study.
Neuroscience letters 1996;204(3):177-80.
-
1996: Helisalmi S; Mannermaa A; Lehtovirta M; Ryynänen M; Riekkinen P; Soininen H
Screening for amyloid beta precursor protein codon 665, 670/671 and 717 mutations in Finnish patients with Alzheimer's disease.
Neuroscience letters 1996;205(1):68-70.
-
1996: Helisalmi S; Linnaranta K; Lehtovirta M; Mannermaa A; Heinonen O; Ryynänen M; Riekkinen P; Soininen H
Apolipoprotein E polymorphism in patients with different neurodegenerative disorders.
Neuroscience letters 1996;205(1):61-4.
-
1996: Lahtinen H; Ylinen A; Lukkarinen U; Sirviö J; Miettinen R; Riekkinen P
Failure of carbamazepine to prevent behavioural and histopathological sequels of experimentally induced status epilepticus.
European journal of pharmacology 1996;297(3):213-8.
-
1996: Pirttilä T; Mehta P D; Soininen H; Kim K S; Heinonen O; Paljärvi L; Kosunen O; Riekkinen P; Wisniewski H M
Cerebrospinal fluid concentrations of soluble amyloid beta-protein and apolipoprotein E in patients with Alzheimer's disease: correlations with amyloid load in the brain.
Archives of neurology 1996;53(2):189-93.
-
1996: Lehtovirta M; Soininen H; Helisalmi S; Mannermaa A; Helkala E L; Hartikainen P; Hänninen T; Ryynänen M; Riekkinen P J
Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism.
Neurology 1996;46(2):413-9.
-
1996: Miettinen M; Koivisto E; Riekkinen P; Miettinen R
Coexistence of parvalbumin and GABA in nonpyramidal neurons of the rat entorhinal cortex.
Brain research 1996;706(1):113-22.
-
1996: Yavich L; Sirviö J; Haapalinna A; Puumala T; Koivisto E; Heinonen E; Riekkinen P J
The systemic administration of tacrine or selegiline facilitate spatial learning in aged fisher 344 rats.
Journal of neural transmission (Vienna, Austria : 1996) 1996;103(5):619-26.
-
1996: Kosunen O; Soininen H; Paljärvi L; Heinonen O; Talasniemi S; Riekkinen P J
Diagnostic accuracy of Alzheimer's disease: a neuropathological study.
Acta neuropathologica 1996;91(2):185-93.
-
1995: Pitkänen M; Sirviö J; MacDonald E; Niemi S; Ekonsalo T; Riekkinen P
The effects of D-cycloserine and MK-801 on the performance of rats in two spatial learning and memory tasks.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1995;5(4):457-63.
-
1995: Soininen H; Lehtovirta M; Helisalmi S; Linnaranta K; Heinonen O; Riekkinen P
Increased acetylcholinesterase activity in the CSF of Alzheimer patients carrying apolipoprotein epsilon4 allele.
Neuroreport 1995;6(18):2518-20.
-
1995: Rimón R; Lepola U; Jolkkonen J; Halonen T; Riekkinen P
Cerebrospinal fluid gamma-aminobutyric acid in patients with panic disorder.
Biological psychiatry 1995;38(11):737-41.
-
1995: Riekkinen M; Sirviö J; Toivanen T; Riekkinen P
Combined treatment with a 5HT1A receptor agonist and a muscarinic acetylcholine receptor antagonist disrupts water maze navigation behavior.
Psychopharmacology 1995;122(2):137-46.
-
1995: Laakso M P; Partanen K; Lehtovirta M; Hallikainen M; Hänninen T; Vainio P; Riekkinen P; Soininen H
MRI of amygdala fails to diagnose early Alzheimer's disease.
Neuroreport 1995;6(17):2414-8.
-
1995: Aikiä M; Kälviäinen R; Riekkinen P J
Verbal learning and memory in newly diagnosed partial epilepsy.
Epilepsy research 1995;22(2):157-64.
-
1995: Valtonen P; Haapalinna A; Riekkinen P; Halonen T
Effect of alpha 2-adrenergic drugs dexmedetomidine and atipamezole on extracellular amino acid levels in vivo.
European journal of pharmacology 1995;285(3):239-46.
-
1995: Kälviäinen R; Aikiä M; Saukkonen A M; Mervaala E; Riekkinen P J
Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy. A randomized, controlled study.
Archives of neurology 1995;52(10):989-96.
-
1995: Halonen T; Kotti T; Tuunanen J; Toppinen A; Miettinen R; Riekkinen P J
Alpha 2-adrenoceptor agonist, dexmedetomidine, protects against kainic acid-induced convulsions and neuronal damage.
Brain research 1995;693(1-2):217-24.
-
1995: Hänninen T; Hallikainen M; Koivisto K; Helkala E L; Reinikainen K J; Soininen H; Mykkänen L; Laakso M; Pyörälä K; Riekkinen P J
A follow-up study of age-associated memory impairment: neuropsychological predictors of dementia.
Journal of the American Geriatrics Society 1995;43(9):1007-15.
-
1995: Pitkänen M; Sirviö J; Ylinen A; Koivisto E; Riekkinen P
Effects of NMDA receptor modulation on hippocampal type 2 theta activity in rats.
General pharmacology 1995;26(5):1065-70.
-
1995: Riekkinen P; Kuitunen J; Riekkinen M
Effects of thalamic and nucleus basalis infusions of nicotine on cortical EEG.
Neuroreport 1995;6(12):1625-8.
-
1995: Tuunainen A; Nousiainen U; Pilke A; Mervaala E; Partanen J; Riekkinen P
Spectral EEG during short-term discontinuation of antiepileptic medication in partial epilepsy.
Epilepsia 1995;36(8):817-23.
-
1995: Miettinen R; Kotti T; Halonen T; Riekkinen P
NADPH diaphorase-containing nonpyramidal cells in the rat hippocampus exhibit differential sensitivity to kainic acid.
The European journal of neuroscience 1995;7(8):1822-5.
-
1995: Jäkälä P; Sirviö J; Koivisto E; Björklund M; Kaukua J; Riekkinen P
Modulation of rat neocortical high-voltage spindle activity by 5-HT1/5-HT2 receptor subtype specific drugs.
European journal of pharmacology 1995;282(1-3):39-55.
-
1995: Heinonen O; Lehtovirta M; Soininen H; Helisalmi S; Mannermaa A; Sorvari H; Kosunen O; Paljärvi L; Ryynänen M; Riekkinen P J
Alzheimer pathology of patients carrying apolipoprotein E epsilon 4 allele.
Neurobiology of aging 1995;16(4):505-13.
-
1995: Riekkinen P; Kuitunen J; Riekkinen M
Effects of scopolamine infusions into the anterior and posterior cingulate on passive avoidance and water maze navigation.
Brain research 1995;685(1-2):46-54.
-
1995: Riekkinen P; Kuikka J; Soininen H; Helkala E L; Hallikainen M; Riekkinen P
Tetrahydroaminoacridine modulates technetium-99m labelled ethylene dicysteinate retention in Alzheimer's disease measured with single photon emission computed tomography imaging.
Neuroscience letters 1995;195(1):53-6.
-
1995: Riekkinen P; Kuikka J; Soininen H; Helkala E L; Hallikainen M; Riekkinen P
Tetrahydroaminoacridine modulates technetium-99m labelled ethylene dicysteinate retention in Alzheimer's disease measured with single photon emission computed tomography imaging.
Neuroscience letters 1995;195(1):53-6.
-
1995: Halonen T; Miettinen R; Toppinen A; Tuunanen J; Kotti T; Riekkinen P J
Vigabatrin protects against kainic acid-induced neuronal damage in the rat hippocampus.
Neuroscience letters 1995;195(1):13-6.
-
1995: Riekkinen P; Soininen H; Helkala E L; Partanen K; Laakso M; Vanhanen M; Riekkinen P
Hippocampal atrophy, acute THA treatment and memory in Alzheimer's disease.
Neuroreport 1995;6(9):1297-300.
-
1995: Riekkinen P; Soininen H; Helkala E L; Partanen K; Laakso M; Vanhanen M; Riekkinen P
Hippocampal atrophy, acute THA treatment and memory in Alzheimer's disease.
Neuroreport 1995;6(9):1297-300.
-
1995: Tuunainen A; Nousiainen U; Hurskainen H; Leinonen E; Pilke A; Mervaala E; Vapalahti M; Partanen J; Riekkinen P
Preoperative EEG predicts memory and selective cognitive functions after temporal lobe surgery.
Journal of neurology, neurosurgery, and psychiatry 1995;58(6):674-80.
-
1995: Riekkinen P; Riekkinen M
Effects of tetrahydroaminoacridine and nicotine in nucleus basalis and serotonin-lesioned rats.
European journal of pharmacology 1995;279(1):65-73.
-
1995: Kosunen O; Talasniemi S; Lehtovirta M; Heinonen O; Helisalmi S; Mannermaa A; Paljärvi L; Ryynänen M; Riekkinen P J; Soininen H
Relation of coronary atherosclerosis and apolipoprotein E genotypes in Alzheimer patients.
Stroke; a journal of cerebral circulation 1995;26(5):743-8.
-
1995: Helkala E L; Koivisto K; Hänninen T; Vanhanen M; Kervinen K; Kuusisto J; Mykkänen L; Kesäniemi Y A; Laakso M; Riekkinen P
The association of apolipoprotein E polymorphism with memory: a population based study.
Neuroscience letters 1995;191(3):141-4.
-
1995: Koivisto K; Reinikainen K J; Hänninen T; Vanhanen M; Helkala E L; Mykkänen L; Laakso M; Pyörälä K; Riekkinen P J
Prevalence of age-associated memory impairment in a randomly selected population from eastern Finland.
Neurology 1995;45(4):741-7.
-
1995: Laakso M; Soininen H; Partanen K; Hallikainen M; Lehtovirta M; Hänninen T; Vainio P; Riekkinen P J
The interuncal distance in Alzheimer disease and age-associated memory impairment.
AJNR. American journal of neuroradiology 1995;16(4):727-34.
-
1995: Soininen H; Kosunen O; Helisalmi S; Mannermaa A; Paljärvi L; Talasniemi S; Ryynänen M; Riekkinen P
A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer patients carrying apolipoprotein epsilon 4 allele.
Neuroscience letters 1995;187(2):79-82.
-
1995: Tuunainen A; Nousiainen U; Pilke A; Mervaala E; Riekkinen P
Lateralization of event-related potentials during discontinuation of antiepileptic medication.
Epilepsia 1995;36(3):262-9.
-
1995: Soininen H; Partanen K; Pitkänen A; Hallikainen M; Hänninen T; Helisalmi S; Mannermaa A; Ryynänen M; Koivisto K; Riekkinen P
Decreased hippocampal volume asymmetry on MRIs in nondemented elderly subjects carrying the apolipoprotein E epsilon 4 allele.
Neurology 1995;45(2):391-2.
-
1995: Ylinen A; Pitkänen M; Sirviö J; Hartikainen T; Sivenius J; Koivisto E; Riekkinen P J
The effects of NMDA receptor antagonists at anticonvulsive doses on the performance of rats in the water maze task.
European journal of pharmacology 1995;274(1-3):159-65.
-
1995: Lehtovirta M; Helisalmi S; Mannermaa A; Soininen H; Koivisto K; Ryynänen M; Riekkinen P
Apolipoprotein E polymorphism and Alzheimer's disease in eastern Finland.
Neuroscience letters 1995;185(1):13-5.
-
1995: Sivenius J; Riekkinen P J; Laakso M
Antiplatelet treatment in elderly people with transient ischaemic attacks or ischaemic strokes.
BMJ (Clinical research ed.) 1995;310(6971):25-6.
-
1995: Heinonen O; Soininen H; Sorvari H; Kosunen O; Paljärvi L; Koivisto E; Riekkinen P J
Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in Alzheimer's disease.
Neuroscience 1995;64(2):375-84.
-
1995: Soininen H; Helkala E L; Kuikka J; Hartikainen P; Lehtovirta M; Riekkinen P J
Regional cerebral blood flow measured by 99mTc-HMPAO SPECT differs in subgroups of Alzheimer's disease.
Journal of neural transmission. Parkinson's disease and dementia section 1995;9(2-3):95-109.
-
1995: Pitkänen M; Sirviö J; MacDonald E; Ekonsalo T; Riekkinen P
The effects of d-cycloserine, a partial agonist at the glycine binding site, on spatial learning and working memory in scopolamine-treated rats.
Journal of neural transmission. Parkinson's disease and dementia section 1995;9(2-3):133-44.
-
1995: Laakso M P; Soininen H; Partanen K; Helkala E L; Hartikainen P; Vainio P; Hallikainen M; Hänninen T; Riekkinen P J
Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: correlation with memory functions.
Journal of neural transmission. Parkinson's disease and dementia section 1995;9(1):73-86.
-
1995: Ylinen A; Kälviäinen R; Riekkinen P J
Long-term efficacy and cognitive effects of vigabatrin.
Acta neurologica Scandinavica. Supplementum 1995;162():47-50.
-
1994: Yavich L; Sirviö J; Haapalinna A; Riekkinen P
Some unusual effects of alpha 2-adrenergic drugs on cortical high voltage spindles in rats.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1994;4(4):535-8.
-
1994: Saukkonen A; Kälviäinen R; Partanen K; Vainio P; Riekkinen P; Pitkänen A
Do seizures cause neuronal damage? A MRI study in newly diagnosed and chronic epilepsy.
Neuroreport 1994;6(1):219-23.
-
1994: Tuunainen A; Nousiainen U; Mervaala E; Pilke A; Vapalahti M; Leinonen E; Paljärvi L; Riekkinen P
Postoperative EEG and electrocorticography: relation to clinical outcome in patients with temporal lobe surgery.
Epilepsia 1994;35(6):1165-73.
-
1994: Sivenius J; Ylinen A; Kälviäinen R; Riekkinen P J
Long-term study with gabapentin in patients with drug-resistant epileptic seizures.
Archives of neurology 1994;51(10):1047-50.
-
1994: Riekkinen P; Sirviö J; Riekkinen M
Serotonin depletion decreases the therapeutic effect of nicotine, but not THA in medial septal-lesioned rats.
Brain research 1994;662(1-2):95-102.
-
1994: Kuusisto J; Koivisto K; Kervinen K; Mykkänen L; Helkala E L; Vanhanen M; Hänninen T; Pyörälä K; Kesäniemi Y A; Riekkinen P
Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study.
BMJ (Clinical research ed.) 1994;309(6955):636-8.
-
1994: Soininen H S; Partanen K; Pitkänen A; Vainio P; Hänninen T; Hallikainen M; Koivisto K; Riekkinen P J
Volumetric MRI analysis of the amygdala and the hippocampus in subjects with age-associated memory impairment: correlation to visual and verbal memory.
Neurology 1994;44(9):1660-8.
-
1994: Riekkinen P
5-HT1A and muscarinic acetylcholine receptors jointly regulate passive avoidance behavior.
European journal of pharmacology 1994;262(1-2):77-90.
-
1994: Heinonen O; Soininen H; Syrjänen S; Neittaanmäki H; Paljärvi L; Kosunen O; Syrjänen K; Riekkinen P
beta-Amyloid protein immunoreactivity in skin is not a reliable marker of Alzheimer's disease. An autopsy-controlled study.
Archives of neurology 1994;51(8):799-804.
-
1994: Kuhmonen J; Sivenius J; Riekkinen P J; Kauppinen R A
Decrease in brain choline-containing compounds following a short period of global ischemia in gerbils as detected by 1H NMR spectroscopy in vivo.
NMR in biomedicine 1994;7(5):231-6.
-
1994: Sirviö J; Riekkinen P; Jäkälä P; Riekkinen P J
Experimental studies on the role of serotonin in cognition.
Progress in neurobiology 1994;43(4-5):363-79.
-
1994: Riekkinen M; Tolonen R; Riekkinen P
Interaction between 5-HT1A and nicotinic cholinergic receptors in the regulation of water maze navigation behavior.
Brain research 1994;649(1-2):174-80.
-
1994: Koponen H J; Leinonen E; Lepola U; Riekkinen P J
A long-term follow-up study of cerebrospinal fluid somatostatin in delirium.
Acta psychiatrica Scandinavica 1994;89(5):329-34.
-
1994: Sirviö J; Lahtinen H; Riekkinen P; Riekkinen P J
Spatial learning and noradrenaline content in the brain and periphery of young and aged rats.
Experimental neurology 1994;125(2):312-5.
-
1994: Sirviö J; Lahtinen H; Riekkinen P; Riekkinen P J
Spatial learning and noradrenaline content in the brain and periphery of young and aged rats.
Experimental neurology 1994;125(2):312-5.
-
1994: Pitkänen M; Sirviö J; Lahtinen H; Koivisto E; Riekkinen P
d-Cycloserine, a partial agonist at the glycine site, enhances the excitability of dentate granule cells in vivo in rats.
European journal of pharmacology 1994;253(1-2):125-9.
-
1994: Riekkinen M; Riekkinen P
Effects of THA and physostigmine on spatial navigation and avoidance performance in mecamylamine and PCPA-treated rats.
Experimental neurology 1994;125(1):111-8.
-
1994: Hänninen T; Reinikainen K J; Helkala E L; Koivisto K; Mykkänen L; Laakso M; Pyörälä K; Riekkinen P J
Subjective memory complaints and personality traits in normal elderly subjects.
Journal of the American Geriatrics Society 1994;42(1):1-4.
-
1994: Koponen H J; Sirviö J; Lepola U; Leinonen E; Riekkinen P J
A long-term follow-up study of cerebrospinal fluid acetylcholinesterase in delirium.
European archives of psychiatry and clinical neuroscience 1994;243(6):347-51.
-
1994: Partanen J; Hartikainen P; Könönen M; Jousmäki V; Soininen H; Riekkinen P
Prolonged latencies of pattern reversal visual evoked early potentials in Alzheimer disease.
Alzheimer disease and associated disorders 1994;8(4):250-8.
-
1994: Sirviö J; Mazurkiewicz M; Haapalinna A; Riekkinen P; Lahtinen H; Riekkinen P J
The effects of selective alpha-2 adrenergic agents on the performance of rats in a 5-choice serial reaction time task.
Brain research bulletin 1994;35(5-6):451-5.
-
1994: Sirviö J; Mazurkiewicz M; Haapalinna A; Riekkinen P; Lahtinen H; Riekkinen P J
The effects of selective alpha-2 adrenergic agents on the performance of rats in a 5-choice serial reaction time task.
Brain research bulletin 1994;35(5-6):451-5.
-
1994: Heinonen O; Kurvinen K; Soininen H; Koponen H; Syrjänen S; Riekkinen P J
Testing for mutations in exon 17 of the beta-amyloid precursor protein gene in Finnish Alzheimer patients and normal subjects.
Journal of neural transmission. Parkinson's disease and dementia section 1994;7(3):211-5.
-
1993: Riekkinen P; Riekkinen M; Sirviö J
Cholinergic drugs regulate passive avoidance performance via the amygdala.
The Journal of pharmacology and experimental therapeutics 1993;267(3):1484-92.
-
1993: Kälviäinen R; Keränen T; Riekkinen P J
Place of newer antiepileptic drugs in the treatment of epilepsy.
Drugs 1993;46(6):1009-24.
-
1993: Riekkinen P; Riekkinen M; Sirviö J
Effects of nicotine on neocortical electrical activity in rats.
The Journal of pharmacology and experimental therapeutics 1993;267(2):776-84.
-
1993: Kuusisto J; Koivisto K; Mykkänen L; Helkala E L; Vanhanen M; Hänninen T; Pyörälä K; Riekkinen P; Laakso M
Essential hypertension and cognitive function. The role of hyperinsulinemia.
Hypertension 1993;22(5):771-9.
-
1993: Lahtinen H; Ylinen A; Hyvönen M; Sirviö J; Miettinen R; Riekkinen P J
Preservation of hippocampal NMDA receptors may be crucial for spatial learning after epileptic seizures in rats.
Brain research 1993;625(1):93-9.
-
1993: Jäkälä P; Mazurkiewicz M; Sirviö J; Riekkinen P; Riekkinen P
The behavioral effects of serotonin synthesis inhibition and quisqualic acid induced lesions of the nucleus basalis magnocellularis in rats.
General pharmacology 1993;24(5):1141-8.
-
1993: Jäkälä P; Mazurkiewicz M; Sirviö J; Riekkinen P; Riekkinen P
The behavioral effects of serotonin synthesis inhibition and quisqualic acid induced lesions of the nucleus basalis magnocellularis in rats.
General pharmacology 1993;24(5):1141-8.
-
1993: Riekkinen M; Sirviö J; Riekkinen P
Pharmacological consequences of nicotinergic plus serotonergic manipulations.
Brain research 1993;622(1-2):139-46.
-
1993: Riekkinen P; Riekkinen M; Fisher A; Ekonsalo T; Sirviö J
Effects of muscarinic receptor agonists and anticholinesterase drugs on high voltage spindles and slow waves.
European journal of pharmacology 1993;240(1):1-7.
-
1993: Keränen T; Riekkinen P J
Remission of seizures in untreated epilepsy.
BMJ (Clinical research ed.) 1993;307(6902):483.
-
1993: Castrén E; Pitkänen M; Sirviö J; Parsadanian A; Lindholm D; Thoenen H; Riekkinen P J
The induction of LTP increases BDNF and NGF mRNA but decreases NT-3 mRNA in the dentate gyrus.
Neuroreport 1993;4(7):895-8.
-
1993: Sivenius J; Riekkinen P J; Lowenthal A; Smets P; Laakso M
Antiplatelet therapy is effective in primary prevention of myocardial infarction in patients with a previous cerebrovascular ischemic event.
Archives of neurology 1993;50(7):710-3.
-
1993: Mazurkiewicz M; Sirviö J; Riekkinen P
Effects of single and repeated administration of vigabatrin on the performance of non-epileptic rats in a delayed non-matching to position task.
Epilepsy research 1993;15(3):221-7.
-
1993: Riekkinen P; Lammintausta R; Ekonsalo T; Sirviö J
The effects of alpha 2-adrenoceptor stimulation on neocortical EEG activity in control and 6-hydroxydopamine dorsal noradrenergic bundle-lesioned rats.
European journal of pharmacology 1993;238(2-3):263-72.
-
1993: Brankack J; Lahtinen H; Koivisto E; Riekkinen P J
Epileptogenic spikes and seizures but not high voltage spindles are induced by local frontal cortical application of gamma-hydroxybutyrate.
Epilepsy research 1993;15(2):91-9.
-
1993: Lahtinen H; Korhonen E; Castrén E; Miettinen R; Ylinen A; Riekkinen P J
Long-term alterations in NMDA-sensitive L-[3H]glutamate binding in the rat hippocampus following fimbria-fornix lesioning.
Experimental neurology 1993;121(2):193-9.
-
1993: Laulumaa V; Kuikka J T; Soininen H; Bergström K; Länsimies E; Riekkinen P
Imaging of D2 dopamine receptors of patients with Parkinson's disease using single photon emission computed tomography and iodobenzamide I 123.
Archives of neurology 1993;50(5):509-12.
-
1993: Jäkälä P; Sirviö J; Riekkinen P J
The effects of tacrine and zacopride on the performance of adult rats in the working memory task.
General pharmacology 1993;24(3):675-9.
-
1993: Mervaala E; Alhainen K; Helkala E L; Partanen J; Jousmäki V; Väyrynen M; Heinonen E; Riekkinen P
Electrophysiological and neuropsychological effects of a central alpha 2-antagonist atipamezole in healthy volunteers.
Behavioural brain research 1993;55(1):85-91.
-
1993: Sirviö J; Jäkälä P; Mazurkiewicz M; Haapalinna A; Riekkinen P; Riekkinen P J
Dose- and parameter-dependent effects of atipamezole, an alpha 2-antagonist, on the performance of rats in a five-choice serial reaction time task.
Pharmacology, biochemistry, and behavior 1993;45(1):123-9.
-
1993: Sirviö J; Jäkälä P; Mazurkiewicz M; Haapalinna A; Riekkinen P; Riekkinen P J
Dose- and parameter-dependent effects of atipamezole, an alpha 2-antagonist, on the performance of rats in a five-choice serial reaction time task.
Pharmacology, biochemistry, and behavior 1993;45(1):123-9.
-
1993: Riekkinen P; Sirviö J; Toivanen L; Riekkinen M; Lammintausta R; Riekkinen P
Alpha 1-adrenoceptor antagonist decreases alpha 2-adrenoceptor antagonist-induced high voltage spindle suppression in adult and aged rats.
European journal of pharmacology 1993;235(2-3):317-20.
-
1993: Riekkinen P; Sirviö J; Toivanen L; Riekkinen M; Lammintausta R; Riekkinen P
Alpha 1-adrenoceptor antagonist decreases alpha 2-adrenoceptor antagonist-induced high voltage spindle suppression in adult and aged rats.
European journal of pharmacology 1993;235(2-3):317-20.
-
1993: Kälviäinen R; Halonen T; Pitkänen A; Riekkinen P J
Amino acid levels in the cerebrospinal fluid of newly diagnosed epileptic patients: effect of vigabatrin and carbamazepine monotherapies.
Journal of neurochemistry 1993;60(4):1244-50.
-
1993: Soininen H; Partanen J; Jousmäki V; Helkala E L; Vanhanen M; Majuri S; Kaski M; Hartikainen P; Riekkinen P
Age-related cognitive decline and electroencephalogram slowing in Down's syndrome as a model of Alzheimer's disease.
Neuroscience 1993;53(1):57-63.
-
1993: Miettinen R; Sirviö J; Riekkinen P; Laakso M P; Riekkinen M; Riekkinen P
Neocortical, hippocampal and septal parvalbumin- and somatostatin-containing neurons in young and aged rats: correlation with passive avoidance and water maze performance.
Neuroscience 1993;53(2):367-78.
-
1993: Miettinen R; Sirviö J; Riekkinen P; Laakso M P; Riekkinen M; Riekkinen P
Neocortical, hippocampal and septal parvalbumin- and somatostatin-containing neurons in young and aged rats: correlation with passive avoidance and water maze performance.
Neuroscience 1993;53(2):367-78.
-
1993: Koponen H J; Riekkinen P J
A prospective study of delirium in elderly patients admitted to a psychiatric hospital.
Psychological medicine 1993;23(1):103-9.
-
1993: Jäkälä P; Sirviö J; Riekkinen P; Riekkinen P J
Effects of p-chlorophenylalanine and methysergide on the performance of a working memory task.
Pharmacology, biochemistry, and behavior 1993;44(2):411-8.
-
1993: Jäkälä P; Sirviö J; Riekkinen P; Riekkinen P J
Effects of p-chlorophenylalanine and methysergide on the performance of a working memory task.
Pharmacology, biochemistry, and behavior 1993;44(2):411-8.
-
1993: Sivenius J; Riekkinen P J; Laakso M; Smets P; Lowenthal A
European Stroke Prevention Study (ESPS): antithrombotic therapy is also effective in the elderly.
Acta neurologica Scandinavica 1993;87(2):111-4.
-
1993: Mazurkiewicz M; Sirviö J; Riekkinen P J
Effects of an inhibitor of GABA-aminotransferase (gamma-vinyl-GABA) on the spatial navigation deficit induced by nicotinic blockade.
General pharmacology 1993;24(1):153-7.
-
1993: Heinonen O; Syrjänen S; Soininen H; Talasniemi S; Kaski M; Mäntyjärvi R; Syrjänen K; Riekkinen P
Circulating immune complexes in sera from patients with Alzheimer's disease, multi-infarct dementia and Down's syndrome.
Neuroscience letters 1993;149(1):67-70.
-
1993: Jolkkonen J; Lepola U; Bissette G; Nemeroff C; Riekkinen P
CSF corticotropin-releasing factor is not affected in panic disorder.
Biological psychiatry 1993;33(2):136-8.
-
1993: Sivenius J; Paljärvi L; Vapalahti M; Nousiainen U; Riekkinen P J
Vigabatrin (gamma-vinyl-GABA): neuropathologic evaluation in five patients.
Epilepsia 1993;34(1):193-6.
-
1993: Pitkänen A; Ylinen A; Matilainen R; Luukkainen R; Mervaala E; Seppänen R; Ruutiainen T; Riekkinen P J
Long-term antiepileptic efficacy of vigabatrin in drug-refractory epilepsy in mentally retarded patients. A 5-year follow-up study.
Archives of neurology 1993;50(1):24-9.
-
1993: Alhainen K; Helkala E L; Riekkinen P
Psychometric discrimination of tetrahydroaminoacridine responders in Alzheimer patients.
Dementia (Basel, Switzerland) 1993;4(1):54-8.
-
1993: Lahtinen H; Castrén E; Miettinen R; Ylinen A; Paljärvi L; Riekkinen P J
NMDA-sensitive [3H]glutamate binding in the epileptic rat hippocampus: an autoradiographic study.
Neuroreport 1993;4(1):45-8.
-
1993: Soininen H; Reinikainen K J; Puranen M; Helkala E L; Paljärvi L; Riekkinen P J
Wide third ventricle correlates with low choline acetyltransferase activity of the neocortex in Alzheimer patients.
Alzheimer disease and associated disorders 1993;7(1):39-47.
-
1993: Lepola U M; Rimón R H; Riekkinen P J
Three-year follow-up of patients with panic disorder after short-term treatment with alprazolam and imipramine.
International clinical psychopharmacology 1993;8(2):115-8.
-
1993: Yavich L; Sirviö J; Heinonen E; Riekkinen P
The interaction of L-deprenyl and scopolamine on spatial learning/memory in rats.
Journal of neural transmission. Parkinson's disease and dementia section 1993;6(3):189-97.
-
1993: Soininen H; Heinonen O; Hallikainen M; Hänninen T; Koivisto K; Syrjänen S; Talasniemi S; Riekkinen P J
Circulating immune complexes in sera from patients with Alzheimer's disease and subjects with age-associated memory impairment.
Journal of neural transmission. Parkinson's disease and dementia section 1993;6(3):179-88.
-
1993: Hartikainen P; Helkala E L; Soininen H; Riekkinen P
Cognitive and memory deficits in untreated Parkinson's disease and amyotrophic lateral sclerosis patients: a comparative study.
Journal of neural transmission. Parkinson's disease and dementia section 1993;6(2):127-37.
-
1993: Lahtinen H; Miettinen R; Ylinen A; Halonen T; Riekkinen P J
Biochemical and morphological changes in the rat hippocampus following transection of the fimbria-fornix.
Brain research bulletin 1993;31(3-4):311-8.
-
1993: Alhainen K; Riekkinen P J
Discrimination of Alzheimer patients responding to cholinesterase inhibitor therapy.
Acta neurologica Scandinavica. Supplementum 1993;149():16-21.
-
1993: Riekkinen P; Riekkinen M; Sirviö J; Riekkinen P
Effects of ZK 93426 on muscarinic and nicotinic antagonist or nucleus basalis lesioning-induced electrocortical slowing.
Psychopharmacology 1993;111(2):195-201.
-
1993: Riekkinen P; Riekkinen M; Sirviö J; Riekkinen P
Effects of ZK 93426 on muscarinic and nicotinic antagonist or nucleus basalis lesioning-induced electrocortical slowing.
Psychopharmacology 1993;111(2):195-201.
-
1993: Soininen H; Riekkinen P
[Regulation of attention]
Duodecim; lääketieteellinen aikakauskirja 1993;109(21):2001-6.
-
1993: Helkala E L; Riekkinen P
[Neuropsychological theories of frontal lobe function]
Duodecim; lääketieteellinen aikakauskirja 1993;109(21):1988-93.
-
1993: Alhainen K; Helkala E L; Reinikainen K; Riekkinen P
The relationship of cerebrospinal fluid monoamine metabolites with clinical response to tetrahydroaminoacridine in patients with Alzheimer's disease.
Journal of neural transmission. Parkinson's disease and dementia section 1993;5(3):185-92.
-
1992: Jolkkonen J; Mazurkiewicz M; Lahtinen H; Riekkinen P
Acute effects of gamma-vinyl GABA on the GABAergic system in rats as studied by microdialysis.
European journal of pharmacology 1992;229(2-3):269-72.
-
1992: Lahtinen H; Brankack J; Koivisto E; Riekkinen P J
Somatostatin release in rat neocortex during gamma-hydroxybutyrate-provoked seizures: microdialysis combined with EEG recording.
Brain research bulletin 1992;29(6):837-41.
-
1992: Kälviäinen R; Aikiä M; Helkala E L; Mervaala E; Riekkinen P J
Memory and attention in newly diagnosed epileptic seizure disorder.
Seizure : the journal of the British Epilepsy Association 1992;1(4):255-62.
-
1992: Mazurkiewicz M; Sirviö J; Riekkinen P
Effects of single and repeated administration of vigabatrin on the performance of rats in a 5-choice serial reaction time task.
Epilepsy research 1992;13(3):231-7.
-
1992: Sirviö J; Ekonsalo T; Riekkinen P; Lahtinen H; Riekkinen P
D-cycloserine, a modulator of the N-methyl-D-aspartate receptor, improves spatial learning in rats treated with muscarinic antagonist.
Neuroscience letters 1992;146(2):215-8.
-
1992: Sirviö J; Ekonsalo T; Riekkinen P; Lahtinen H; Riekkinen P
D-cycloserine, a modulator of the N-methyl-D-aspartate receptor, improves spatial learning in rats treated with muscarinic antagonist.
Neuroscience letters 1992;146(2):215-8.
-
1992: Soininen H; Puranen M; Helkala E L; Laakso M; Riekkinen P J
Diabetes mellitus and brain atrophy: a computed tomography study in an elderly population.
Neurobiology of aging 1992;13(6):717-21.
-
1992: Mervaala E; Nousiainen U; Kinnunen J; Vapalahti M; Riekkinen P
Pre- and postoperative auditory event-related potentials in temporal lobe epilepsy.
Epilepsia 1992;33(6):1029-35.
-
1992: Jäkälä P; Viitamaa T; Sirviö J; Riekkinen P; Salonen J; Haapalinna A; Virtanen R; Riekkinen P
Continuous alpha 2-adrenoceptor blockade by atipamezole decreases neocortical high-voltage spindle activity in rats.
European journal of pharmacology 1992;221(2-3):351-7.
-
1992: Jäkälä P; Viitamaa T; Sirviö J; Riekkinen P; Salonen J; Haapalinna A; Virtanen R; Riekkinen P
Continuous alpha 2-adrenoceptor blockade by atipamezole decreases neocortical high-voltage spindle activity in rats.
European journal of pharmacology 1992;221(2-3):351-7.
-
1992: Jäkälä P; Sirviö J; Jolkkonen J; Riekkinen P; Acsady L; Riekkinen P
The effects of p-chlorophenylalanine-induced serotonin synthesis inhibition and muscarinic blockade on the performance of rats in a 5-choice serial reaction time task.
Behavioural brain research 1992;51(1):29-40.
-
1992: Jäkälä P; Sirviö J; Jolkkonen J; Riekkinen P; Acsady L; Riekkinen P
The effects of p-chlorophenylalanine-induced serotonin synthesis inhibition and muscarinic blockade on the performance of rats in a 5-choice serial reaction time task.
Behavioural brain research 1992;51(1):29-40.
-
1992: Mazurkiewicz M; Sirviö J; Riekkinen P J
Effects of an inhibitor of GABA-aminotransferase (gamma-vinyl-GABA) on the spatial navigation deficit induced by muscarinic blockade.
Pharmacology, biochemistry, and behavior 1992;43(1):91-6.
-
1992: Ylinen A; Sivenius J; Pitkänen A; Halonen T; Partanen J; Mervaala E; Mumford J P; Riekkinen P J
Gamma-vinyl GABA (vigabatrin) in epilepsy: clinical, neurochemical, and neurophysiologic monitoring in epileptic patients.
Epilepsia 1992;33(5):917-22.
-
1992: Mazurkiewicz M; Sirviö J; Riekkinen P
Attenuation by the benzodiazepine receptor antagonist, ZK 93 426, of the deficit in spatial navigation induced by nucleus basalis lesions.
Behavioral and neural biology 1992;58(2):159-63.
-
1992: Soininen H; Reinikainen K J; Partanen J; Helkala E L; Paljärvi L; Riekkinen P J
Slowing of electroencephalogram and choline acetyltransferase activity in post mortem frontal cortex in definite Alzheimer's disease.
Neuroscience 1992;49(3):529-35.
-
1992: Hartikainen P; Soininen H; Partanen J; Helkala E L; Riekkinen P
Aging and spectral analysis of EEG in normal subjects: a link to memory and CSF AChE.
Acta neurologica Scandinavica 1992;86(2):148-55.
-
1992: Jäkälä P; Sirviö J; Riekkinen P; Haapalanna A; Riekkinen P
Effects of atipamezole, an alpha 2-adrenoceptor antagonist, on the performance of rats in a five-choice serial reaction time task.
Pharmacology, biochemistry, and behavior 1992;42(4):903-7.
-
1992: Jäkälä P; Sirviö J; Riekkinen P; Haapalanna A; Riekkinen P
Effects of atipamezole, an alpha 2-adrenoceptor antagonist, on the performance of rats in a five-choice serial reaction time task.
Pharmacology, biochemistry, and behavior 1992;42(4):903-7.
-
1992: Riekkinen M; Riekkinen P; Sirviö J; Riekkinen P
Effects of combined methysergide and mecamylamine/scopolamine treatment on spatial navigation.
Brain research 1992;585(1-2):322-6.
-
1992: Riekkinen M; Riekkinen P; Sirviö J; Riekkinen P
Effects of combined methysergide and mecamylamine/scopolamine treatment on spatial navigation.
Brain research 1992;585(1-2):322-6.
-
1992: Koivisto K; Helkala E L; Reinikainen K J; Hänninen T; Mykkänen L; Laakso M; Pyörälä K; Riekkinen P J
Population-based dementia screening program in Kuopio: the effect of education, age, and sex on brief neuropsychological tests.
Journal of geriatric psychiatry and neurology 1992;5(3):162-71.
-
1992: Riekkinen P; Sirviö J; Ekonsalo T; Riekkinen P
Effects of noradrenergic DSP4 lesion on the effectiveness of pilocarpine in reversing scopolamine-induced amnesia.
Brain research bulletin 1992;28(6):919-22.
-
1992: Riekkinen P; Sirviö J; Ekonsalo T; Riekkinen P
Effects of noradrenergic DSP4 lesion on the effectiveness of pilocarpine in reversing scopolamine-induced amnesia.
Brain research bulletin 1992;28(6):919-22.
-
1992: Sivenius J; Laakso M; Riekkinen P; Smets P; Lowenthal A
European stroke prevention study: effectiveness of antiplatelet therapy in diabetic patients in secondary prevention of stroke.
Stroke; a journal of cerebral circulation 1992;23(6):851-4.
-
1992: Jolkkonen J; Pitkänen A; Riekkinen P J; Korpi E R; Kaufmann C A; Weinberger D R
Somatostatin-like immunoreactivity in CSF in schizophrenic patients during haloperidol treatment.
Biological psychiatry 1992;31(9):962-4.
-
1992: Aikiä M; Kälviäinen R; Sivenius J; Halonen T; Riekkinen P J
Cognitive effects of oxcarbazepine and phenytoin monotherapy in newly diagnosed epilepsy: one year follow-up.
Epilepsy research 1992;11(3):199-203.
-
1992: Nieminen S A; Sirviö J; Teittinen K; Pitkänen A; Airaksinen M M; Riekkinen P
Amygdala kindling increased fear-response, but did not impair spatial memory in rats.
Physiology & behavior 1992;51(4):845-9.
-
1992: Riekkinen P; Riekkinen M; Sirviö J; Riekkinen P
Neurophysiological consequences of combined cholinergic and noradrenergic lesions.
Experimental neurology 1992;116(1):64-8.
-
1992: Riekkinen P; Riekkinen M; Sirviö J; Riekkinen P
Neurophysiological consequences of combined cholinergic and noradrenergic lesions.
Experimental neurology 1992;116(1):64-8.
-
1992: Yavich L B; Airaksinen M M; Riekkinen P J
Fast cyclic voltammetry of oxidizable species; depth profile in the rat striatum with and without potassium stimulation of the median forebrain bundle.
Brain research 1992;578(1-2):149-54.
-
1992: Heinonen O; Syrjänen S; Mäntyjärvi R; Syrjänen K; Riekkinen P
JC virus infection and Alzheimer's disease: reappraisal of an in situ hybridization approach.
Annals of neurology 1992;31(4):439-41.
-
1992: Soininen H; Reinikainen K; Partanen J; Mervaala E; Paljärvi L; Helkala E L; Riekkinen P
Slowing of the dominant occipital rhythm in electroencephalogram is associated with low concentration of noradrenaline in the thalamus in patients with Alzheimer's disease.
Neuroscience letters 1992;137(1):5-8.
-
1992: Riekkinen P; Riekkinen M; Sirviö J
Effects of tetrahydroaminoacridine on spatial navigation of nucleus-basalis- and frontal-cortex-lesioned rats.
Pharmacology, biochemistry, and behavior 1992;41(3):637-41.
-
1992: Riekkinen P; Riekkinen M; Sirviö J; Riekkinen P
Effects of concurrent nicotinic antagonist and PCPA treatments on spatial and passive avoidance learning.
Brain research 1992;575(2):247-50.
-
1992: Riekkinen P; Riekkinen M; Sirviö J; Riekkinen P
Effects of concurrent nicotinic antagonist and PCPA treatments on spatial and passive avoidance learning.
Brain research 1992;575(2):247-50.
-
1992: Riekkinen P; Sirviö J; Riekkinen M; Lammintausta R; Riekkinen P
Atipamezole, an alpha 2 antagonist, stabilizes age-related high-voltage spindle and passive avoidance defects.
Pharmacology, biochemistry, and behavior 1992;41(3):611-4.
-
1992: Riekkinen P; Sirviö J; Riekkinen M; Lammintausta R; Riekkinen P
Atipamezole, an alpha 2 antagonist, stabilizes age-related high-voltage spindle and passive avoidance defects.
Pharmacology, biochemistry, and behavior 1992;41(3):611-4.
-
1992: Sirviö J; Riekkinen P; Ekonsalo T; Lammintausta R; Riekkinen P J
The effects of dexmedetomidine, an alpha 2 agonist, on learning and memory, assessed using passive avoidance and water maze tasks in rats.
Neuropharmacology 1992;31(2):163-8.
-
1992: Sirviö J; Riekkinen P; Ekonsalo T; Lammintausta R; Riekkinen P J
The effects of dexmedetomidine, an alpha 2 agonist, on learning and memory, assessed using passive avoidance and water maze tasks in rats.
Neuropharmacology 1992;31(2):163-8.
-
1992: Halonen T; Pitkänen A; Koivisto E; Partanen J; Riekkinen P J
Effect of vigabatrin on the electroencephalogram in rats.
Epilepsia 1992;33(1):122-7.
-
1992: Riekkinen P; Riekkinen M; Valjakka A; Riekkinen P; Sirviö J
DSP-4, a noradrenergic neurotoxin, produces more severe biochemical and functional deficits in aged than young rats.
Brain research 1992;570(1-2):293-9.
-
1992: Riekkinen P; Riekkinen M; Valjakka A; Riekkinen P; Sirviö J
DSP-4, a noradrenergic neurotoxin, produces more severe biochemical and functional deficits in aged than young rats.
Brain research 1992;570(1-2):293-9.
-
1992: Ylinen A; Koivisto E; Valjakka A; Sirviö J; Freund T F; Riekkinen P
Hippocampal mobility-related theta activity is not diminished by vigabatrin, a GABAmimetic antiepileptic drug, in normal rats.
Brain research bulletin 1992;28(1):145-7.
-
1992: Freund T F; Ylinen A; Miettinen R; Pitkänen A; Lahtinen H; Baimbridge K G; Riekkinen P J
Pattern of neuronal death in the rat hippocampus after status epilepticus. Relationship to calcium binding protein content and ischemic vulnerability.
Brain research bulletin 1992;28(1):27-38.
-
1992: Soininen H; Syrjänen S; Heinonen O; Neittaanmäki H; Miettinen R; Paljärvi L; Syrjänen K; Beyreuther K; Riekkinen P
Amyloid beta-protein deposition in skin of patients with dementia.
Lancet 1992;339(8787):245.
-
1992: Soininen H; Helkala E L; Laulumaa V; Soikkeli R; Hartikainen P; Riekkinen P J
Cognitive profile of Alzheimer patients with extrapyramidal signs: a longitudinal study.
Journal of neural transmission. Parkinson's disease and dementia section 1992;4(3):241-54.
-
1992: Riekkinen P; Riekkinen M; Sirviö J; Miettinen R; Riekkinen P
Loss of cholinergic neurons in the nucleus basalis induces neocortical electroencephalographic and passive avoidance deficits.
Neuroscience 1992;47(4):823-31.
-
1992: Riekkinen P; Riekkinen M; Sirviö J; Miettinen R; Riekkinen P
Loss of cholinergic neurons in the nucleus basalis induces neocortical electroencephalographic and passive avoidance deficits.
Neuroscience 1992;47(4):823-31.
-
1992: Jäkälä P; Sirviö J; Riekkinen P; Valjakka A; Riekkinen P
The effects of alaproclate and p-chlorophenylalanine on cued navigation performance in rats.
Journal of neural transmission. Parkinson's disease and dementia section 1992;4(1):43-52.
-
1992: Jäkälä P; Sirviö J; Riekkinen P; Valjakka A; Riekkinen P
The effects of alaproclate and p-chlorophenylalanine on cued navigation performance in rats.
Journal of neural transmission. Parkinson's disease and dementia section 1992;4(1):43-52.
-
1992: Soininen H; Riekkinen P J
EEG in diagnostics and follow-up of Alzheimer's disease.
Acta neurologica Scandinavica. Supplementum 1992;139():36-9.
-
1992: Sirviö J; Riekkinen P J
Brain and cerebrospinal fluid cholinesterases in Alzheimer's disease, Parkinson's disease and aging. A critical review of clinical and experimental studies.
Journal of neural transmission. Parkinson's disease and dementia section 1992;4():337-58.
-
1992: Mervaala E; Nousiainen U; Tuunainen A; Partanen J; Riekkinen P
[Sinus arrest in a patient with sleep apnea syndrome associated with an increase in alertness]
Duodecim; lääketieteellinen aikakauskirja 1992;108(11):1063-6.
-
1992: Sirviö J; Harju M; Riekkinen P; Haapalinna A; Riekkinen P J
Comparative effects of alpha-2 receptor agents and THA on the performance of adult and aged rats in the delayed non-matching to position task.
Psychopharmacology 1992;109(1-2):127-33.
-
1992: Sirviö J; Harju M; Riekkinen P; Haapalinna A; Riekkinen P J
Comparative effects of alpha-2 receptor agents and THA on the performance of adult and aged rats in the delayed non-matching to position task.
Psychopharmacology 1992;109(1-2):127-33.
-
1992: Halonen T; Pitkänen A; Partanen J; Hyttinen J M; Riekkinen P J
Amino acid levels in cerebrospinal fluid of rats after administration of pentylenetetrazol.
Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology 1992;101(1):21-5.
-
1992: Sirviö J; Riekkinen P; MacDonald E; Airaksinen M; Lammintausta R; Riekkinen P J
The effects of alpha-2 adrenoceptor antagonist, atipamezole, on spatial learning in scopolamine-treated and aged rats.
Journal of neural transmission. Parkinson's disease and dementia section 1992;4(2):99-106.
-
1992: Sirviö J; Riekkinen P; MacDonald E; Airaksinen M; Lammintausta R; Riekkinen P J
The effects of alpha-2 adrenoceptor antagonist, atipamezole, on spatial learning in scopolamine-treated and aged rats.
Journal of neural transmission. Parkinson's disease and dementia section 1992;4(2):99-106.
-
1992: Soininen H; Laulumaa V; Helkala E L; Hartikainen P; Riekkinen P J
Extrapyramidal signs in Alzheimer's disease: a 3-year follow-up study.
Journal of neural transmission. Parkinson's disease and dementia section 1992;4(2):107-19.
-
1992: Hartikainen P; Reinikainen K J; Soininen H; Sirviö J; Soikkeli R; Riekkinen P J
Neurochemical markers in the cerebrospinal fluid of patients with Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis and normal controls.
Journal of neural transmission. Parkinson's disease and dementia section 1992;4(1):53-68.
-
1991: Riekkinen P; Sirviö J; Riekkinen M; Valjakka A; Koivisto E; Riekkinen P
Gammavinylgaba increases high voltage spindle activity in control and nucleus basalis-lesioned rats after sub-chronic treatment.
Brain research 1991;565(2):341-4.
-
1991: Riekkinen P; Sirviö J; Riekkinen M; Valjakka A; Koivisto E; Riekkinen P
Gammavinylgaba increases high voltage spindle activity in control and nucleus basalis-lesioned rats after sub-chronic treatment.
Brain research 1991;565(2):341-4.
-
1991: Sirviö J; Riekkinen P; Valjakka A; Jolkkonen J; Riekkinen P J
The effects of noradrenergic neurotoxin, DSP-4, on the performance of young and aged rats in spatial navigation task.
Brain research 1991;563(1-2):297-302.
-
1991: Sirviö J; Riekkinen P; Valjakka A; Jolkkonen J; Riekkinen P J
The effects of noradrenergic neurotoxin, DSP-4, on the performance of young and aged rats in spatial navigation task.
Brain research 1991;563(1-2):297-302.
-
1991: Riekkinen P; Riekkinen M; Lahtinen H; Sirviö J; Valjakka A; Riekkinen P
Tetrahydroaminoacridine improves passive avoidance retention defects induced by aging and medial septal lesion but not by fimbria-fornix lesion.
Brain research bulletin 1991;27(5):587-94.
-
1991: Riekkinen P; Riekkinen M; Lahtinen H; Sirviö J; Valjakka A; Riekkinen P
Tetrahydroaminoacridine improves passive avoidance retention defects induced by aging and medial septal lesion but not by fimbria-fornix lesion.
Brain research bulletin 1991;27(5):587-94.
-
1991: Soininen H; Partanen J; Laulumaa V; Pääkkönen A; Helkala E L; Riekkinen P J
Serial EEG in Alzheimer's disease: 3 year follow-up and clinical outcome.
Electroencephalography and clinical neurophysiology 1991;79(5):342-8.
-
1991: Riekkinen P; Sirviö J; Jäkälä P; Riekkinen M; Lammintausta R; Riekkinen P
Effects of alpha 2-drugs and pilocarpine on the high-voltage spindle activity of young and aged control and DSP4-lesioned rats.
Physiology & behavior 1991;50(5):955-9.
-
1991: Riekkinen P; Sirviö J; Jäkälä P; Riekkinen M; Lammintausta R; Riekkinen P
Effects of alpha 2-drugs and pilocarpine on the high-voltage spindle activity of young and aged control and DSP4-lesioned rats.
Physiology & behavior 1991;50(5):955-9.
-
1991: Sivenius J; Riekkinen P J; Kilpeläinen H; Laakso M; Penttilä I
Antiplatelet therapy is effective in the prevention of stroke or death in women: subgroup analysis of the European Stroke Prevention Study (ESPS).
Acta neurologica Scandinavica 1991;84(4):286-90.
-
1991: Riekkinen P; Sirviö J; Riekkinen M; Riekkinen P
EEG changes induced by acute and chronic quisqualic or ibotenic acid nucleus basalis lesions are stabilized by tacridine.
Brain research 1991;559(2):304-8.
-
1991: Riekkinen P; Sirviö J; Riekkinen M; Riekkinen P
EEG changes induced by acute and chronic quisqualic or ibotenic acid nucleus basalis lesions are stabilized by tacridine.
Brain research 1991;559(2):304-8.
-
1991: Syrjänen S; Heinonen O; Miettinen R; Paljärvi L; Syrjänen K; Riekkinen P
Short biotinylated oligonucleotides bind non-specifically to senile plaques of Alzheimer's disease.
Neuroscience letters 1991;130(1):89-91.
-
1991: Soikkeli R; Partanen J; Soininen H; Pääkkönen A; Riekkinen P
Slowing of EEG in Parkinson's disease.
Electroencephalography and clinical neurophysiology 1991;79(3):159-65.
-
1991: Alhainen K; Sirviö J; Helkala E L; Reinikainen K; Riekkinen P
Somatostatin and cognitive functions in Alzheimer's disease--the relationship of cerebrospinal fluid somatostatin increase with clinical response to tetrahydroaminoacridine.
Neuroscience letters 1991;130(1):46-8.
-
1991: Ylinen A M; Miettinen R; Pitkänen A; Gulyas A I; Freund T F; Riekkinen P J
Enhanced GABAergic inhibition preserves hippocampal structure and function in a model of epilepsy.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(17):7650-3.
-
1991: Sivenius J; Laakso M; Penttilä I M; Smets P; Lowenthal A; Riekkinen P J
The European Stroke Prevention Study: results according to sex.
Neurology 1991;41(8):1189-92.
-
1991: Riekkinen P; Sirviö J; Riekkinen M; Riekkinen P
Effects of THA on passive avoidance retention performance of intact, nucleus basalis, frontal cortex and nucleus basalis + frontal cortex-lesioned rats.
Pharmacology, biochemistry, and behavior 1991;39(4):841-6.
-
1991: Riekkinen P; Sirviö J; Riekkinen M; Riekkinen P
Effects of THA on passive avoidance retention performance of intact, nucleus basalis, frontal cortex and nucleus basalis + frontal cortex-lesioned rats.
Pharmacology, biochemistry, and behavior 1991;39(4):841-6.
-
1991: Koponen H; Sirviö J; Reinikainen K J; Riekkinen P J
A longitudinal study of cerebrospinal fluid acetylcholinesterase in delirium: changes at the acute stage and at one-year followup.
Psychiatry research 1991;38(2):135-42.
-
1991: Riekkinen P; Riekkinen M; Sirviö J; Miettinen R; Riekkinen P
Comparison of the effects of acute and chronic ibotenic and quisqualic acid nucleus basalis lesioning.
Brain research bulletin 1991;27(2):199-206.
-
1991: Riekkinen P; Riekkinen M; Sirviö J; Miettinen R; Riekkinen P
Comparison of the effects of acute and chronic ibotenic and quisqualic acid nucleus basalis lesioning.
Brain research bulletin 1991;27(2):199-206.
-
1991: Sirviö J; Lukkarinen K; Riekkinen P; Koivisto E; Virtanen R; Pennanen A; Valjakka A; Riekkinen P J
The effects of atipamezole, an alpha-2 antagonist, on the performance of young and aged rats in the delayed nonmatching to position task.
Pharmacology, biochemistry, and behavior 1991;39(4):1015-9.
-
1991: Sirviö J; Lukkarinen K; Riekkinen P; Koivisto E; Virtanen R; Pennanen A; Valjakka A; Riekkinen P J
The effects of atipamezole, an alpha-2 antagonist, on the performance of young and aged rats in the delayed nonmatching to position task.
Pharmacology, biochemistry, and behavior 1991;39(4):1015-9.
-
1991: Riekkinen P; Riekkinen M; Jäkälä P; Sirvioö J; Lammintausta R; Riekkinen P
Combination of atipamezole and tetrahydroaminoacridine/pilocarpine treatment suppresses high voltage spindle activity in aged rats.
Brain research bulletin 1991;27(2):237-9.
-
1991: Riekkinen P; Riekkinen M; Jäkälä P; Sirvioö J; Lammintausta R; Riekkinen P
Combination of atipamezole and tetrahydroaminoacridine/pilocarpine treatment suppresses high voltage spindle activity in aged rats.
Brain research bulletin 1991;27(2):237-9.
-
1991: Riekkinen P; Sirviö J; Valjakka A; Riekkinen M; Lammintausta R; Riekkinen P
Effects of atipamezole and tetrahydroaminoacridine on nucleus basalis lesion-induced EEG changes.
Brain research bulletin 1991;27(2):231-5.
-
1991: Riekkinen P; Sirviö J; Valjakka A; Riekkinen M; Lammintausta R; Riekkinen P
Effects of atipamezole and tetrahydroaminoacridine on nucleus basalis lesion-induced EEG changes.
Brain research bulletin 1991;27(2):231-5.
-
1991: Riekkinen P; Sirviö J; Jäkälä P; Mazurkiewicz M; Valjakka A; Riekkinen M; Riekkinen P
Increased GABAergic transmission aggravates nucleus basalis magnocellularis lesion-induced behavioral deficits.
Brain research bulletin 1991;27(2):287-9.
-
1991: Riekkinen P; Sirviö J; Jäkälä P; Mazurkiewicz M; Valjakka A; Riekkinen M; Riekkinen P
Increased GABAergic transmission aggravates nucleus basalis magnocellularis lesion-induced behavioral deficits.
Brain research bulletin 1991;27(2):287-9.
-
1991: Riekkinen P; Koivisto E; Sirviö J; Riekkinen P
Joint modulation of neocortical electrical activity by nicotinic and muscarinic receptors.
Brain research bulletin 1991;27(1):137-9.
-
1991: Riekkinen P; Koivisto E; Sirviö J; Riekkinen P
Joint modulation of neocortical electrical activity by nicotinic and muscarinic receptors.
Brain research bulletin 1991;27(1):137-9.
-
1991: Riekkinen M; Riekkinen P; Riekkinen P
Comparison of quisqualic and ibotenic acid nucleus basalis magnocellularis lesions on water-maze and passive avoidance performance.
Brain research bulletin 1991;27(1):119-23.
-
1991: Riekkinen M; Riekkinen P; Riekkinen P
Comparison of quisqualic and ibotenic acid nucleus basalis magnocellularis lesions on water-maze and passive avoidance performance.
Brain research bulletin 1991;27(1):119-23.
-
1991: Sivenius J; Kälviäinen R; Ylinen A; Riekkinen P
Double-blind study of Gabapentin in the treatment of partial seizures.
Epilepsia 1991;32(4):539-42.
-
1991: Aaltonen M; Riekkinen P; Sirviö J; Riekkinen P
Effects of THA on passive avoidance and spatial performance in quisqualic acid nucleus basalis-lesioned rats.
Pharmacology, biochemistry, and behavior 1991;39(3):563-7.
-
1991: Aaltonen M; Riekkinen P; Sirviö J; Riekkinen P
Effects of THA on passive avoidance and spatial performance in quisqualic acid nucleus basalis-lesioned rats.
Pharmacology, biochemistry, and behavior 1991;39(3):563-7.
-
1991: Ylinen A; Lahtinen H; Sirviö J; Partanen J; Asikainen A; Gulyas A; Freund T F; Riekkinen P
Behavioural, electrophysiological and histopathological changes following sustained stimulation of the perforant pathway input to the hippocampus: effect of the NMDA receptor antagonist, CGP 39551.
Brain research 1991;553(2):195-200.
-
1991: Ylinen A; Valjakka A; Lahtinen H; Miettinen R; Freund T F; Riekkinen P
Vigabatrin pre-treatment prevents hilar somatostatin cell loss and the development of interictal spiking activity following sustained simulation of the perforant path.
Neuropeptides 1991;19(3):205-11.
-
1991: Sirviö J; Riekkinen P; Vajanto I; Koivisto E; Riekkinen P J
The effects of guanfacine, alpha-2 agonist, on the performance of young and aged rats in spatial navigation task.
Behavioral and neural biology 1991;56(1):101-7.
-
1991: Sirviö J; Riekkinen P; Vajanto I; Koivisto E; Riekkinen P J
The effects of guanfacine, alpha-2 agonist, on the performance of young and aged rats in spatial navigation task.
Behavioral and neural biology 1991;56(1):101-7.
-
1991: Riekkinen P; Sirviö J; Valjakka A; Miettinen R; Riekkinen P
Pharmacological consequences of cholinergic plus serotonergic manipulations.
Brain research 1991;552(1):23-6.
-
1991: Riekkinen P; Sirviö J; Valjakka A; Miettinen R; Riekkinen P
Pharmacological consequences of cholinergic plus serotonergic manipulations.
Brain research 1991;552(1):23-6.
-
1991: Riekkinen P; Aaltonen M; Sirviö J; Riekkinen P
Tetrahydroaminoacridine alleviates medial septal lesion-induced and age-related spatial reference but not working memory deficits.
Physiology & behavior 1991;49(6):1147-52.
-
1991: Riekkinen P; Aaltonen M; Sirviö J; Riekkinen P
Tetrahydroaminoacridine alleviates medial septal lesion-induced and age-related spatial reference but not working memory deficits.
Physiology & behavior 1991;49(6):1147-52.
-
1991: Sivenius J; Riekkinen P J; Smets P; Laakso M; Lowenthal A
The European Stroke Prevention Study (ESPS): results by arterial distribution.
Annals of neurology 1991;29(6):596-600.
-
1991: Koponen H; Riekkinen P J
Cerebrospinal fluid acetylcholinesterase in patients with dementia associated with schizophrenia or chronic alcoholism.
Acta psychiatrica Scandinavica 1991;83(6):441-3.
-
1991: Alhainen K; Partanen J; Reinikainen K; Laulumaa V; Soininen H; Airaksinen M; Riekkinen P
Discrimination of tetrahydroaminoacridine responders by a single dose pharmaco-EEG in patients with Alzheimer's disease.
Neuroscience letters 1991;127(1):113-6.
-
1991: Helkala E L; Laulumaa V; Soikkeli R; Partanen J; Soininen H; Riekkinen P J
Slow-wave activity in the spectral analysis of the electroencephalogram is associated with cortical dysfunctions in patients with Alzheimer's disease.
Behavioral neuroscience 1991;105(3):409-15.
-
1991: Jolkkonen J; Hartikainen P; Soikkeli R; Bissette G; Nemeroff C; Riekkinen P
A correlation study of CSF neuropeptides in Alzheimer's and Parkinson's disease.
Neuropeptides 1991;19(2):97-102.
-
1991: Riekkinen P; Jäkälä P; Sirviö J; Riekkinen P
The effects of increased serotonergic and decreased cholinergic activities on spatial navigation performance in rats.
Pharmacology, biochemistry, and behavior 1991;39(1):25-9.
-
1991: Riekkinen P; Jäkälä P; Sirviö J; Riekkinen P
The effects of increased serotonergic and decreased cholinergic activities on spatial navigation performance in rats.
Pharmacology, biochemistry, and behavior 1991;39(1):25-9.
-
1991: Sirviö J; Ylinen A; Lahtinen H; Ronkainen A; Riekkinen P; Halonen T; Riekkinen P J
The effect of subchronic administration of vigabatrin on learning and memory in nonepileptic rats.
Pharmacology, biochemistry, and behavior 1991;39(1):205-10.
-
1991: Sirviö J; Ylinen A; Lahtinen H; Ronkainen A; Riekkinen P; Halonen T; Riekkinen P J
The effect of subchronic administration of vigabatrin on learning and memory in nonepileptic rats.
Pharmacology, biochemistry, and behavior 1991;39(1):205-10.
-
1991: Airaksinen M S; Reinikainen K; Riekkinen P; Panula P
Neurofibrillary tangles and histamine-containing neurons in Alzheimer hypothalamus.
Agents and actions 1991;33(1-2):104-7.
-
1991: Valjakka A; Lukkarinen K; Koivisto E; Riekkinen P; Miettinen R; Airaksinen M M; Lammintausta R; Riekkinen P
Modulation of EEG rhythmicity and spike activity in the rat hippocampus by systemically administered tetrahydroaminoacridine, scopolamine and atipamezole.
Brain research bulletin 1991;26(5):739-45.
-
1991: Valjakka A; Lukkarinen K; Koivisto E; Riekkinen P; Miettinen R; Airaksinen M M; Lammintausta R; Riekkinen P
Modulation of EEG rhythmicity and spike activity in the rat hippocampus by systemically administered tetrahydroaminoacridine, scopolamine and atipamezole.
Brain research bulletin 1991;26(5):739-45.
-
1991: Koponen H; Honkonen S; Partanen J; Riekkinen P J
Epileptic attack, delirium, and periodic complexes in the EEG during mianserin treatment.
Journal of neurology, neurosurgery, and psychiatry 1991;54(4):379.
-
1991: Helkala E L; Laulumaa V; Soininen H; Partanen J; Riekkinen P J
Different patterns of cognitive decline related to normal or deteriorating EEG in a 3-year follow-up study of patients with Alzheimer's disease.
Neurology 1991;41(4):528-32.
-
1991: Sivenius J; Ylinen A; Murros K; Mumford J P; Riekkinen P J
Vigabatrin in drug-resistant partial epilepsy: a 5-year follow-up study.
Neurology 1991;41(4):562-5.
-
1991: Riekkinen P; Jäkälä P; Sirviö J; Koivisto E; Miettinen R; Riekkinen P
The effects of THA on scopolamine and nucleus basalis lesion-induced EEG slowing.
Brain research bulletin 1991;26(4):633-7.
-
1991: Riekkinen P; Jäkälä P; Sirviö J; Koivisto E; Miettinen R; Riekkinen P
The effects of THA on scopolamine and nucleus basalis lesion-induced EEG slowing.
Brain research bulletin 1991;26(4):633-7.
-
1991: Valjakka A; Lukkarinen K; Koivisto E; Lammintausta R; Airaksinen M M; Riekkinen P
Evoked field responses, recurrent inhibition, long-term potentiation and immobility-related nonrhythmical EEG in the dentate gyrus of fimbria-fornix-lesioned and control rats.
Brain research bulletin 1991;26(4):525-32.
-
1991: Nousiainen U; Partanen J; Koivisto K; Soininen H; Riekkinen P J
Electroneuromyographic findings in patients with Alzheimer's disease.
Electromyography and clinical neurophysiology 1991;31(2):119-22.
-
1991: Henriksson T; Barbour R M; Braa S; Ward P; Fritz L C; Johnson-Wood K; Chung H D; Burke W; Reinikainen K J; Riekkinen P
Analysis and quantitation of the beta-amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients with a monoclonal antibody-based immunoassay.
Journal of neurochemistry 1991;56(3):1037-42.
-
1991: Halonen T; Pitkänen A; Saano V; Riekkinen P J
Effects of vigabatrin (gamma-vinyl GABA) on neurotransmission-related amino acids and on GABA and benzodiazepine receptor binding in rats.
Epilepsia 1991;32(2):242-9.
-
1991: Soininen H; Partanen J; Pääkkönen A; Koivisto E; Riekkinen P J
Changes in absolute power values of EEG spectra in the follow-up of Alzheimer's disease.
Acta neurologica Scandinavica 1991;83(2):133-6.
-
1991: Riekkinen P; Buzsaki G; Riekkinen P; Soininen H; Partanen J
The cholinergic system and EEG slow waves.
Electroencephalography and clinical neurophysiology 1991;78(2):89-96.
-
1991: Riekkinen P; Buzsaki G; Riekkinen P; Soininen H; Partanen J
The cholinergic system and EEG slow waves.
Electroencephalography and clinical neurophysiology 1991;78(2):89-96.
-
1991: Riekkinen P; Aaltonen M; Riekkinen P
Tetrahydroaminoacridine inhibits high voltage spindle activity in aged rats after acute and chronic treatment.
Psychopharmacology 1991;103(2):265-7.
-
1991: Riekkinen P; Aaltonen M; Riekkinen P
Tetrahydroaminoacridine inhibits high voltage spindle activity in aged rats after acute and chronic treatment.
Psychopharmacology 1991;103(2):265-7.
-
1991: Sirviö J; Rakonczay Z; Hartikainen P; Kasa P; Riekkinen P J
The molecular forms of acetylcholinesterase in cerebrospinal fluid of normal subjects--effect of aging.
Journal of neural transmission. General section 1991;86(2):147-50.
-
1991: Kälviäinen R; Aikiä M; Partanen J; Sivenius J; Mumford J; Saksa M; Riekkinen P J
Randomized controlled pilot study of vigabatrin versus carbamazepine monotherapy in newly diagnosed patients with epilepsy: an interim report.
Journal of child neurology 1991;Suppl 2():S60-9.
-
1991: Riekkinen P; Sirviö J; Riekkinen P
Non-reversal of scopolamine- or age-related EEG changes by ondansetron, methysergide or alaproclate.
Psychopharmacology 1991;103(4):567-70.
-
1991: Riekkinen P; Sirviö J; Riekkinen P
Non-reversal of scopolamine- or age-related EEG changes by ondansetron, methysergide or alaproclate.
Psychopharmacology 1991;103(4):567-70.
-
1991: Airaksinen M S; Paetau A; Paljärvi L; Reinikainen K; Riekkinen P; Suomalainen R; Panula P
Histamine neurons in human hypothalamus: anatomy in normal and Alzheimer diseased brains.
Neuroscience 1991;44(2):465-81.
-
1991: Hartikainen P; Soininen H; Reinikainen K J; Sirviö J; Soikkeli R; Riekkinen P J
Neurotransmitter markers in the cerebrospinal fluid of normal subjects. Effects of aging and other confounding factors.
Journal of neural transmission. General section 1991;84(1-2):103-17.
-
1991: Koponen H; Honkonen S; Partanen J; Riekkinen P J
[Symptoms of Creutzfeldt-Jakob disease during mianserin therapy]
Duodecim; lääketieteellinen aikakauskirja 1991;107(3):173-5.
-
1990: Halonen T; Pitkänen A; Riekkinen P J
Administration of vigabatrin (gamma-vinyl-gamma-aminobutyric acid) affects the levels of both inhibitory and excitatory amino acids in rat cerebrospinal fluid.
Journal of neurochemistry 1990;55(6):1870-4.
-
1990: Hannila T; Sirviö J; Riekkinen P J
The effect of gamma-vinyl-GABA on the performance of nucleus basalis-lesioned rats in spatial navigation task.
Brain research 1990;537(1-2):363-6.
-
1990: Reinikainen K J; Soininen H; Riekkinen P J
Neurotransmitter changes in Alzheimer's disease: implications to diagnostics and therapy.
Journal of neuroscience research 1990;27(4):576-86.
-
1990: Koponen H; Reinikainen K J; Jolkkonen J T; Riekkinen P J
Somatostatin-like immunoreactivity in the CSF of patients with dementia associated with alcoholism.
Acta neurologica Scandinavica 1990;82(5):289-91.
-
1990: Riekkinen P; Sirviö J; Aaltonen M; Riekkinen P
Effects of concurrent manipulations of nicotinic and muscarinic receptors on spatial and passive avoidance learning.
Pharmacology, biochemistry, and behavior 1990;37(3):405-10.
-
1990: Riekkinen P; Sirviö J; Aaltonen M; Riekkinen P
Effects of concurrent manipulations of nicotinic and muscarinic receptors on spatial and passive avoidance learning.
Pharmacology, biochemistry, and behavior 1990;37(3):405-10.
-
1990: Valjakka A; Riekkinen P; Sirviö J; Nieminen S; Airaksinen M; Miettinen R; Riekkinen P
The effects of dorsal noradrenergic bundle lesions on spatial learning, locomotor activity, and reaction to novelty.
Behavioral and neural biology 1990;54(3):323-9.
-
1990: Valjakka A; Riekkinen P; Sirviö J; Nieminen S; Airaksinen M; Miettinen R; Riekkinen P
The effects of dorsal noradrenergic bundle lesions on spatial learning, locomotor activity, and reaction to novelty.
Behavioral and neural biology 1990;54(3):323-9.
-
1990: Riekkinen P; Sirviö J; Jäkälä P; Lammintausta R; Riekkinen P
Effect of alpha2 antagonists and an agonist on EEG slowing induced by scopolamine and lesion of the nucleus basalis.
Neuropharmacology 1990;29(11):993-9.
-
1990: Riekkinen P; Sirviö J; Jäkälä P; Lammintausta R; Riekkinen P
Effect of alpha2 antagonists and an agonist on EEG slowing induced by scopolamine and lesion of the nucleus basalis.
Neuropharmacology 1990;29(11):993-9.
-
1990: Lepola U; Nousiainen U; Puranen M; Riekkinen P; Rimón R
EEG and CT findings in patients with panic disorder.
Biological psychiatry 1990;28(8):721-7.
-
1990: Riekkinen P; Miettinen R; Sirviö J; Aaltonen M; Riekkinen P
The correlation of passive avoidance deficit in aged rat with the loss of nucleus basalis choline acetyltransferase-positive neurons.
Brain research bulletin 1990;25(3):415-7.
-
1990: Riekkinen P; Miettinen R; Sirviö J; Aaltonen M; Riekkinen P
The correlation of passive avoidance deficit in aged rat with the loss of nucleus basalis choline acetyltransferase-positive neurons.
Brain research bulletin 1990;25(3):415-7.
-
1990: Riekkinen P; Sirviö J; Riekkinen P
Interaction between raphe dorsalis and nucleus basalis magnocellularis in spatial learning.
Brain research 1990;527(2):342-5.
-
1990: Riekkinen P; Sirviö J; Riekkinen P
Interaction between raphe dorsalis and nucleus basalis magnocellularis in spatial learning.
Brain research 1990;527(2):342-5.
-
1990: Reinikainen K J; Koponen H; Jolkkonen J; Riekkinen P J
Decreased somatostatin-like immunoreactivity in the cerebrospinal fluid of chronic schizophrenic patients with cognitive impairment.
Psychiatry research 1990;33(3):307-12.
-
1990: Riekkinen P; Sirviö J; Valjakka A; Pitkänen A; Partanen J; Riekkinen P
The effects of concurrent manipulations of cholinergic and noradrenergic systems on neocortical EEG and spatial learning.
Behavioral and neural biology 1990;54(2):204-10.
-
1990: Riekkinen P; Sirviö J; Valjakka A; Pitkänen A; Partanen J; Riekkinen P
The effects of concurrent manipulations of cholinergic and noradrenergic systems on neocortical EEG and spatial learning.
Behavioral and neural biology 1990;54(2):204-10.
-
1990: Lahtinen H; Pitkänen A; Tuomisto L; Riekkinen P
Effect of antiepileptic drugs on somatostatin release in vitro.
Neuropeptides 1990;17(1):29-34.
-
1990: Riekkinen P J; Pitkänen A
Somatostatin and epilepsy.
Metabolism: clinical and experimental 1990;39(9 Suppl 2):112-5.
-
1990: Riekkinen P; Sirviö J; Miettinen R; Riekkinen P
Interaction between raphe dorsalis and nucleus basalis magnocellularis in the regulation of high-voltage spindle activity in rat neocortex.
Brain research 1990;526(1):31-6.
-
1990: Riekkinen P; Sirviö J; Miettinen R; Riekkinen P
Interaction between raphe dorsalis and nucleus basalis magnocellularis in the regulation of high-voltage spindle activity in rat neocortex.
Brain research 1990;526(1):31-6.
-
1990: Koponen H; Reinikainen K; Riekkinen P J
Cerebrospinal fluid somatostatin in delirium. II. Changes at the acute stage and at one year follow-up.
Psychological medicine 1990;20(3):501-5.
-
1990: Tuunainen A; Nousiainen U; Mervaala E; Riekkinen P
Efficacy of a 1- to 3-day ambulatory electroencephalogram in recording epileptic seizures.
Archives of neurology 1990;47(7):799-800.
-
1990: Wolters E C; Riekkinen P; Lowenthal A; Van der Plaats J J; Zwart J M; Sennef C
DGAVP (Org 5667) in early Alzheimer's disease patients: an international double-blind, placebo-controlled, multicenter trial.
Neurology 1990;40(7):1099-101.
-
1990: Riekkinen P; Sirviö J; Jäkälä P; Lammintausta R; Riekkinen P
Interaction between the alpha 2-noradrenergic and muscarinic systems in the regulation of neocortical high voltage spindles.
Brain research bulletin 1990;25(1):147-9.
-
1990: Riekkinen P; Sirviö J; Jäkälä P; Lammintausta R; Riekkinen P
Interaction between the alpha 2-noradrenergic and muscarinic systems in the regulation of neocortical high voltage spindles.
Brain research bulletin 1990;25(1):147-9.
-
1990: Riekkinen P; Sirviö J; Riekkinen P
The effects of THA on medial septal lesion-induced memory defects.
Pharmacology, biochemistry, and behavior 1990;36(2):237-41.
-
1990: Riekkinen P; Sirviö J; Riekkinen P
The effects of THA on medial septal lesion-induced memory defects.
Pharmacology, biochemistry, and behavior 1990;36(2):237-41.
-
1990: Riekkinen P; Sirviö J; Hannila T; Miettinen R; Riekkinen P
Effects of quisqualic acid nucleus basalis lesioning on cortical EEG, passive avoidance and water maze performance.
Brain research bulletin 1990;24(6):839-42.
-
1990: Riekkinen P; Sirviö J; Hannila T; Miettinen R; Riekkinen P
Effects of quisqualic acid nucleus basalis lesioning on cortical EEG, passive avoidance and water maze performance.
Brain research bulletin 1990;24(6):839-42.
-
1990: Riekkinen P; Sirviö J; Riekkinen P
Relationship between the cortical choline acetyltransferase content and EEG delta-power.
Neuroscience research 1990;8(1):12-20.
-
1990: Riekkinen P; Sirviö J; Riekkinen P
Relationship between the cortical choline acetyltransferase content and EEG delta-power.
Neuroscience research 1990;8(1):12-20.
-
1990: Kälviäinen R; Keränen T; Mustonen J; Länsimies E; Riekkinen P J
Autonomic nervous system function in Baltic myoclonus epilepsy.
Epilepsy research 1990;5(3):251-4.
-
1990: Sivenius J; Savolainen S; Kaski M; Riekkinen P J
Therapeutic intervention in mentally retarded adult epileptics.
Acta neurologica Scandinavica 1990;81(2):165-7.
-
1990: Riekkinen P; Sirviö J; Riekkinen P
Similar memory impairments found in medial septal-vertical diagonal band of Broca and nucleus basalis lesioned rats: are memory defects induced by nucleus basalis lesions related to the degree of non-specific subcortical cell loss?
Behavioural brain research 1990;37(1):81-8.
-
1990: Riekkinen P; Sirviö J; Riekkinen P
Similar memory impairments found in medial septal-vertical diagonal band of Broca and nucleus basalis lesioned rats: are memory defects induced by nucleus basalis lesions related to the degree of non-specific subcortical cell loss?
Behavioural brain research 1990;37(1):81-8.
-
1990: Koponen H; Honkonen S; Partanen J; Riekkinen P J
Epileptic attack, delirium, and a Creutzfeldt-Jakob-like syndrome during mianserin treatment.
Neuropsychobiology 1990;23(3):164-8.
-
1990: Valjakka A; Sirviö J; Pitkänen A; Riekkinen P J
Brain amines and neocortical EEG in young and aged rats.
Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology 1990;96(2):299-304.
-
1990: Lepola U; Jolkkonen J; Pitkänen A; Riekkinen P; Rimón R
Cerebrospinal fluid monoamine metabolites and neuropeptides in patients with panic disorder.
Annals of medicine 1990;22(4):237-9.
-
1990: Riekkinen P J; Sirviö J; Riekkinen P
[Neurobiology of memory]
Duodecim; lääketieteellinen aikakauskirja 1990;106(22):1616-25.
-
1990: Riekkinen P J; Sirviö J; Riekkinen P
[Neurobiology of memory]
Duodecim; lääketieteellinen aikakauskirja 1990;106(22):1616-25.
-
1989: Nousiainen U; Mervaala E; Ylinen A; Uusitupa M; Riekkinen P
The importance of the electrocardiogram in ambulatory electroencephalographic recordings.
Archives of neurology 1989;46(11):1171-4.
-
1989: Reinikainen K J; Pitkänen A; Riekkinen P J
2',3'-cyclic nucleotide-3'-phosphodiesterase activity as an index of myelin in the post-mortem brains of patients with Alzheimer's disease.
Neuroscience letters 1989;106(1-2):229-32.
-
1989: Pitkänen A; Beal M F; Sirviö J; Swartz K J; Männistö P T; Riekkinen P J
Somatostatin, neuropeptide Y, GABA and cholinergic enzymes in brain of pentylenetetrazol-kindled rats.
Neuropeptides 1989;14(3):197-207.
-
1989: Koponen H; Partanen J; Pääkkönen A; Mattila E; Riekkinen P J
EEG spectral analysis in delirium.
Journal of neurology, neurosurgery, and psychiatry 1989;52(8):980-5.
-
1989: Koponen H; Stenbäck U; Mattila E; Reinikainen K; Soininen H; Riekkinen P J
Cerebrospinal fluid somatostatin in delirium.
Psychological medicine 1989;19(3):605-9.
-
1989: Keränen T; Riekkinen P J; Sillanpää M
Incidence and prevalence of epilepsy in adults in eastern Finland.
Epilepsia 1989;30(4):413-21.
-
1989: Pitkänen A; Hyttinen J M; Riekkinen P J
Effect of cysteamine on somatostatin-like immunoreactivity in the amygdala-kindled rat brain.
Neuropeptides 1989;14(1):11-6.
-
1989: Pitkänen A; Valjakka A; Pääkkönen A; Sirviö J; Jousmäki V; Partanen J; Riekkinen P J
Effect of cysteamine on levels of somatostatin-like immunoreactivity and catecholamines and on electroencephalogram in the rat brain.
Neuropeptides 1989;14(1):1-9.
-
1989: Koponen H; Stenbäck U; Mattila E; Soininen H; Reinikainen K; Riekkinen P J
Delirium among elderly persons admitted to a psychiatric hospital: clinical course during the acute stage and one-year follow-up.
Acta psychiatrica Scandinavica 1989;79(6):579-85.
-
1989: Koponen H; Hurri L; Stenbäck U; Mattila E; Soininen H; Riekkinen P J
Computed tomography findings in delirium.
The Journal of nervous and mental disease 1989;177(4):226-31.
-
1989: Koponen H; Stenbäck U; Mattila E; Reinikainen K; Soininen H; Riekkinen P J
CSF beta-endorphin-like immunoreactivity in delirium.
Biological psychiatry 1989;25(7):938-44.
-
1989: Soininen H; Partanen J; Laulumaa V; Helkala E L; Laakso M; Riekkinen P J
Longitudinal EEG spectral analysis in early stage of Alzheimer's disease.
Electroencephalography and clinical neurophysiology 1989;72(4):290-7.
-
1989: Mervaala E; Partanen J; Nousianinen U; Sivenius J; Riekkinen P
Electrophysiologic effects of gamma-vinyl GABA and carbamazepine.
Epilepsia 1989;30(2):189-93.
-
1989: Sirviö J; Rinne J O; Valjakka A; Rinne U K; Riekkinen P J; Paljärvi L
Different forms of brain acetylcholinesterase and muscarinic binding in Parkinson's disease.
Journal of the neurological sciences 1989;90(1):23-32.
-
1989: Pitkänen A; Hyttinen J M; Sirviö J; Jolkkonen J; Sarlund H; Riekkinen P
The levels of somatostatin in the brain and CSF of rat after carbamazepine administration.
Pharmacology & toxicology 1989;64(3):266-71.
-
1989: Sirviö J; Riekkinen P J; Hervonen A
Age-dependence of the solubility fractions of acetylcholinesterase in the cerebral cortex and cerebellum of the rat.
Neuroscience letters 1989;96(2):218-22.
-
1989: Pitkänen A; Lepola U; Ylinen A; Riekkinen P J
Somatostatin and beta-endorphin levels in cerebrospinal fluid of nonmedicated and medicated patients with epileptic seizures.
Neuropeptides 1989;13(1):9-15.
-
1989: Sirviö J; Kutvonen R; Soininen H; Hartikainen P; Riekkinen P J
Cholinesterases in the cerebrospinal fluid, plasma, and erythrocytes of patients with Alzheimer's disease.
Journal of neural transmission 1989;75(2):119-27.
-
1989: Riekkinen P J; Pitkanen A; Ylinen A; Sivenius J; Halonen T
Specificity of vigabatrin for the GABAergic system in human epilepsy.
Epilepsia 1989;30 Suppl 3():S18-22.
-
1989: Riekkinen P J; Ylinen A; Halonen T; Sivenius J; Pitkanen A
Cerebrospinal fluid GABA and seizure control with vigabatrin.
British journal of clinical pharmacology 1989;27 Suppl 1():87S-94S.
-
1989: Matilainen R; Pitkänen A; Ruutiainen T; Mervaala E; Riekkinen P
Vigabatrin in epilepsy in mentally retarded patients.
British journal of clinical pharmacology 1989;27 Suppl 1():113S-118S.
-
1989: Helkala E L; Laulumaa V; Soininen H; Riekkinen P J
Different error pattern of episodic and semantic memory in Alzheimer's disease and Parkinson's disease with dementia.
Neuropsychologia 1989;27(10):1241-8.
-
1989: Sirviö J; Pitkänen A; Pääkkönen A; Partanen J; Riekkinen P J
Brain cholinergic enzymes and cortical EEG activity in young and old rats.
Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology 1989;94(1):277-83.
-
1989: Pitkänen A; Matilainen R; Halonen T; Kutvonen R; Hartikainen P; Riekkinen P
Inhibitory and excitatory amino acids in cerebrospinal fluid of chronic epileptic patients.
Journal of neural transmission 1989;76(3):221-30.
-
1989: Lepola U; Jolkkonen J; Rimón R; Riekkinen P
Long-term effects of alprazolam and imipramine on cerebrospinal fluid monoamine metabolites and neuropeptides in panic disorder.
Neuropsychobiology 1989;21(4):182-6.
-
1989: Jolkkonen J; Helkala E L; Kutvonen R; Lehtinen M; Riekkinen P J
Vasopressin levels in CSF of Alzheimer patients: correlations with monoamine metabolites and neuropsychological test performance.
Psychoneuroendocrinology 1989;14(1-2):89-95.
-
1988: Pitkänen A; Matilainen R; Ruutiainen T; Riekkinen P
Levels of total gamma-aminobutyric acid (GABA), free GABA and homocarnosine in cerebrospinal fluid of epileptic patients before and during gamma-vinyl-GABA (vigabatrin) treatment.
Journal of the neurological sciences 1988;88(1-3):83-93.
-
1988: Pitkänen A; Matilainen R; Ruutiainen T; Lehtinen M; Riekkinen P
Effect of vigabatrin (gamma-vinyl GABA) on amino acid levels in CSF of epileptic patients.
Journal of neurology, neurosurgery, and psychiatry 1988;51(11):1395-400.
-
1988: Helkala E L; Laulumaa V; Soininen H; Riekkinen P J
Recall and recognition memory in patients with Alzheimer's and Parkinson's diseases.
Annals of neurology 1988;24(2):214-7.
-
1988: Danner R; Partanen J; Keränen T; Reinikainen K; Hallikainen E; Riekkinen P
Comparison of the effects of carbamazepine and oxcarbazepine on peripheral nerve conduction.
Epilepsy research 1988;2(4):272-5.
-
1988: Halonen T; Lehtinen M; Pitkänen A; Ylinen A; Riekkinen P J
Inhibitory and excitatory amino acids in CSF of patients suffering from complex partial seizures during chronic treatment with gamma-vinyl GABA (vigabatrin).
Epilepsy research 1988;2(4):246-52.
-
1988: Reinikainen K J; Paljärvi L; Halonen T; Malminen O; Kosma V M; Laakso M; Riekkinen P J
Dopaminergic system and monoamine oxidase-B activity in Alzheimer's disease.
Neurobiology of aging 1988;9(3):245-52.
-
1988: Matilainen R; Pitkänen A; Ruutiainen T; Mervaala E; Sarlund H; Riekkinen P
Effect of vigabatrin on epilepsy in mentally retarded patients: a 7-month follow-up study.
Neurology 1988;38(5):743-7.
-
1988: Sirviö J; Hervonen A; Riekkinen P J
Sodium dependent uptake of 3H-choline in the cerebral cortex of ageing male rats.
Pharmacology & toxicology 1988;62(4):227-9.
-
1988: Jolkkonen J; Tuomisto L; van Wimersma Greidanus T B; Riekkinen P J
Vasopressin levels in the cerebrospinal fluid of rats with lesions of the paraventricular and suprachiasmatic nuclei.
Neuroscience letters 1988;86(2):184-8.
-
1988: Sivenius J; Pitkänen A; Matilainen R; Ylinen A; Holonen T; Partanen J; Riekkinen P J
Studies on gamma-vinyl-GABA in Kuopio, Finland.
British journal of clinical practice. Supplement 1988;61():31-2.
-
1988: Reinikainen K J; Paljärvi L; Huuskonen M; Soininen H; Laakso M; Riekkinen P J
A post-mortem study of noradrenergic, serotonergic and GABAergic neurons in Alzheimer's disease.
Journal of the neurological sciences 1988;84(1):101-16.
-
1988: Reinikainen K J; Riekkinen P J; Paljärvi L; Soininen H; Helkala E L; Jolkkonen J; Laakso M
Cholinergic deficit in Alzheimer's disease: a study based on CSF and autopsy data.
Neurochemical research 1988;13(2):135-46.
-
1988: Soininen H; Riekkinen P J; Partanen J; Helkala E L; Laulumaa V; Jolkkonen J; Reinikainen K
Cerebrospinal fluid somatostatin correlates with spectral EEG variables and with parietotemporal cognitive dysfunction in Alzheimer patients.
Neuroscience letters 1988;85(1):131-6.
-
1988: Sivenius J; Heinonen E; Lehto H; Järvensivu P; Anttila M; Ylinen A; Riekkinen P
Reduction of dosing frequency of carbamazepine with a slow-release preparation.
Epilepsy research 1988;2(1):32-6.
-
1988: Keränen T; Sillanpää M; Riekkinen P J
Distribution of seizure types in an epileptic population.
Epilepsia 1988;29(1):1-7.
-
1988: Pitkänen A; Jolkkonen J; Aikiä M; Sirviö J; Sivenius J; Riekkinen P J
Somatostatin-like immunoreactivity in cerebrospinal fluid of patients with complex partial epilepsy.
European neurology 1988;28(1):1-5.
-
1988: Reinikainen K; Saksa M; Murros K; Kulju T; Partanen J; Paljärvi L; Riekkinen P
[Subacute sclerosing panencephalitis in an adult]
Duodecim; lääketieteellinen aikakauskirja 1988;104(21):1712-7.
-
1988: Sirviö J; Hervonen A; Valjakka A; Riekkinen P J
Pre- and postsynaptic markers of cholinergic neurons in the cerebral cortex of rats of different ages.
Experimental gerontology 1988;23(6):473-9.
-
1988: Keränen T; Riekkinen P
Severe epilepsy: diagnostic and epidemiological aspects.
Acta neurologica Scandinavica. Supplementum 1988;117():7-14.
-
1988: Pitkänen A; Jolkkonen J; Sirviö J; Riekkinen P
Somatostatin-like immunoreactivity and somatostatin receptor binding in rat brain in pentylenetetrazol-induced kindling.
Peptides 1988;9 Suppl 1():105-7.
-
1988: Sirviö J; Valjakka A; Jolkkonen J; Hervonen A; Riekkinen P J
Cholinergic enzyme activities and muscarinic binding in the cerebral cortex of rats of different age and sex.
Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology 1988;90(1):245-8.
-
1988: Sirviö J; Hervonen A; Riekkinen P J
Cholinergic binding in the hippocampus of the aging male rat.
Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology 1988;90(1):161-3.
-
1988: Jolkkonen J; Tuomisto L; Van Wimersma Greidanus T B; Läärä E; Riekkinen P
Effects of osmotic stimuli on vasopressin levels in the CSF of rats.
Peptides 1988;9 Suppl 1():109-11.
-
1988: Riekkinen P J; Pitkänen A; Halonen T; Lehtinen M; Ylinen A; Sivenius J
Effect of gamma-vinyl GABA treatment on cholinergic and aminergic neurotransmission and on cyclic nucleotides in human complex partial epilepsy--a CSF study.
Progress in neuro-psychopharmacology & biological psychiatry 1988;12(1):81-91.
-
1987: Koponen H; Hurri L; Stenbäck U; Riekkinen P J
Acute confusional states in the elderly: a radiological evaluation.
Acta psychiatrica Scandinavica 1987;76(6):726-31.
-
1987: Sirviö J; Soininen H S; Kutvonen R; Hyttinen J M; Helkala E L; Riekkinen P J
Acetyl- and butyrylcholinesterase activity in the cerebrospinal fluid of patients with Parkinson's disease.
Journal of the neurological sciences 1987;81(2-3):273-9.
-
1987: Sivenius M R; Ylinen A; Murros K; Matilainen R; Riekkinen P
Double-blind dose reduction study of vigabatrin in complex partial epilepsy.
Epilepsia 1987;28(6):688-92.
-
1987: Pitkänen A; Jolkkonen J; Riekkinen P
Beta-endorphin, somatostatin, and prolactin levels in cerebrospinal fluid of epileptic patients after generalised convulsion.
Journal of neurology, neurosurgery, and psychiatry 1987;50(10):1294-7.
-
1987: Reinikainen K J; Keränen T; Halonen T; Komulainen H; Riekkinen P J
Comparison of oxcarbazepine and carbamazepine: a double-blind study.
Epilepsy research 1987;1(5):284-9.
-
1987: Airaksinen E M; Koivisto K; Keränen T; Pitkänen A; Riekkinen P J; Oja S S; Marnela K M; Partanen J V; Tokola O; Gothóni G
Biochemical and clinical studies on epileptic patients during two phase I trials with the novel anticonvulsant taltrimide.
Epilepsy research 1987;1(5):308-11.
-
1987: Pitkänen A; Saano V; Tuomisto L; Riekkinen P J
Effect of anticonvulsant drugs on (35S)t-butylbicyclophosphorothionate binding in vitro and ex vivo.
Pharmacology & toxicology 1987;61(2):103-6.
-
1987: Reinikainen K J; Riekkinen P J; Halonen T; Laakso M
Decreased muscarinic receptor binding in cerebral cortex and hippocampus in Alzheimer's disease.
Life sciences 1987;41(4):453-61.
-
1987: Reinikainen K J; Keränen T; Lehtinen J M; Kälviäinen R; Saari T; Riekkinen P J
CT brain scan and EEG in the diagnosis of adult onset seizures.
Epilepsy research 1987;1(3):178-84.
-
1987: Jolkkonen J; Lehtinen M; Soininen H; Sennef C; Riekkinen P
Enhanced monoaminergic neurotransmission by desglycinamide-arginine-vasopressin in human subjects.
Neuroscience letters 1987;76(3):312-5.
-
1987: Pitkänen A; Halonen T; Ylinen A; Riekkinen P
Somatostatin, beta-endorphin, and prolactin levels in human cerebrospinal fluid during the gamma-vinyl-GABA treatment of patients with complex partial epilepsy.
Neuropeptides 1987;9(3):185-95.
-
1987: Keränen T; Partanen V S; Koivisto K; Tokola O; Neuvonen P J; Riekkinen P J
Effects of taltrimide, an experimental taurine derivative, on photoconvulsive response in epileptic patients.
Epilepsia 1987;28(2):133-7.
-
1987: Riekkinen P; Legros J J; Sennef C; Jolkkonen J; Smitz S; Soininen H
Penetration of DGAVP (Org 5667) across the blood-brain barrier in human subjects.
Peptides 1987;8(2):261-5.
-
1987: Jolkkonen J T; Soininen H S; Riekkinen P J
beta-Endorphin-like immunoreactivity in cerebrospinal fluid of patients with Alzheimer's disease and Parkinson's disease.
Journal of the neurological sciences 1987;77(2-3):153-9.
-
1987: Reinikainen K J; Riekkinen P J; Jolkkonen J; Kosma V M; Soininen H
Decreased somatostatin-like immunoreactivity in cerebral cortex and cerebrospinal fluid in Alzheimer's disease.
Brain research 1987;402(1):103-8.
-
1987: Pitkänen A; Riekkinen P J; Halonen T; Ylinen A; Ruutiainen T; Lehtinen M
Amino acid levels in human CSF after generalized seizure.
Journal of neural transmission 1987;70(3-4):313-9.
-
1987: Riekkinen P J; Soininen H; Sirviö J; Reinikainen K; Helkala E L; Paljärvi L
Dementia without cholinergic deficit.
Gerontology 1987;33(3-4):268-72.
-
1987: Riekkinen P J; Laulumaa V; Sirviö J; Soininen H; Helkala E L
Recent progress in the research of Alzheimer's disease.
Medical biology 1987;65(2-3):83-8.
-
1986: Jolkkonen J; Soininen H; Halonen T; Ylinen A; Laulumaa V; Laakso M; Riekkinen P
Somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with Parkinson's disease and its relation to dementia.
Journal of neurology, neurosurgery, and psychiatry 1986;49(12):1374-7.
-
1986: Mervaala E; Keränen T; Pääkkönen A; Partanen J V; Riekkinen P
Visual evoked potentials, brainstem auditory evoked potentials, and quantitative EEG in Baltic progressive myoclonus epilepsy.
Epilepsia 1986;27(5):542-7.
-
1986: Partanen J V; Soininen H; Riekkinen P J
Does an ACTH derivative (Org 2766) prevent deterioration of EEG in Alzheimer's disease?
Electroencephalography and clinical neurophysiology 1986;63(6):547-51.
-
1986: Koivisto K; Sivenius J; Keränen T; Partanen J; Riekkinen P; Gothoni G; Tokola O; Neuvonen P J
Clinical trial with an experimental taurine derivative, taltrimide, in epileptic patients.
Epilepsia 1986;27(1):87-90.
-
1986: Jolkkonen J; Tuomisto L; van Wimersma Greidanus T B; Läärä E; Riekkinen P J
Vasopressin levels in the cerebrospinal fluid in rats of different age and sex.
Neuroendocrinology 1986;44(2):163-7.
-
1985: Mervaala E; Keränen T; Penttilä M; Partanen J V; Riekkinen P
Pattern-reversal VEP and cortical SEP latency prolongations in epilepsy.
Epilepsia 1985;26(5):441-5.
-
1985: Soininen H; Koskinen T; Helkala E L; Pigache R; Riekkinen P J
Treatment of Alzheimer's disease with a synthetic ACTH 4-9 analog.
Neurology 1985;35(9):1348-51.
-
1985: Jolkkonen J T; Soininen H S; Riekkinen P J
The effect of ACTH4-9 analog (Org2766) on some cerebrospinal fluid parameters in patients with Alzheimer's disease.
Life sciences 1985;37(7):585-90.
-
1985: Penttilä M; Partanen J V; Soininen H; Riekkinen P J
Quantitative analysis of occipital EEG in different stages of Alzheimer's disease.
Electroencephalography and clinical neurophysiology 1985;60(1):1-6.
-
1984: Soininen H; Pitkänen A; Halonen T; Riekkinen P J
Dopamine-beta-hydroxylase and acetylcholinesterase activities of cerebrospinal fluid in Alzheimer's disease.
Acta neurologica Scandinavica 1984;70(1):29-34.
-
1984: Herranen J; Huhtikangas A; Tirronen H; Halonen T; Huuskonen M; Reinikainen K; Riekkinen P
Quantification of a number of biogenic amines and their metabolites in brain homogenates by gas chromatography--mass spectrometry.
Journal of chromatography 1984;307(2):241-9.
-
1984: Mervaala E; Partanen J V; Keränen T; Penttilä M; Riekkinen P
Prolonged cortical somatosensory evoked potential latencies in progressive myoclonus epilepsy.
Journal of the neurological sciences 1984;64(2):131-5.
-
1984: Soininen H S; Jolkkonen J T; Reinikainen K J; Halonen T O; Riekkinen P J
Reduced cholinesterase activity and somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with dementia of the Alzheimer type.
Journal of the neurological sciences 1984;63(2):167-72.
-
1984: Penttilä M; Partanen J; Soininen H; Riekkinen P
[Quantitative EEG in various forms of Alzheimer's disease]
Duodecim; lääketieteellinen aikakauskirja 1984;100(18):1174-9.
-
1983: Soininen H; Partanen J; Puranen M; Riekkinen P
[EEG and computer tomographic findings in senile dementia]
Duodecim; lääketieteellinen aikakauskirja 1983;99(5):342-6.
-
1983: Reinikainen K; Riekkinen P J
[The role of neurotransmitters in the pathogenesis and treatment of Alzheimer's disease]
Duodecim; lääketieteellinen aikakauskirja 1983;99(6):379-87.
-
1982: Danner R; Leino E; Partanen J; Sorvari T; Riekkinen P
Electroneuromyographical and morphological findings in progressive myoclonus epilepsy (PME).
Acta neurologica Scandinavica 1982;66(6):673-80.
-
1982: Soininen H; Partanen J V; Puranen M; Riekkinen P J
EEG and computed tomography in the investigation of patients with senile dementia.
Journal of neurology, neurosurgery, and psychiatry 1982;45(8):711-4.
-
1982: Soininen H; Partanen V J; Helkala E L; Riekkinen P J
EEG findings in senile dementia and normal aging.
Acta neurologica Scandinavica 1982;65(1):59-70.
-
1982: Soininen H; Puranen M; Riekkinen P J
Computed tomography findings in senile dementia and normal aging.
Journal of neurology, neurosurgery, and psychiatry 1982;45(1):50-4.
-
1982: Leino E; Partanen J; Helkala E L; Riekkinen P J
Clinical stages of progressive myoclonus epilepsy in adult patients.
Acta neurologica Scandinavica 1982;65(1):19-29.
-
1981: Soininen H; Halonen T; Riekkinen P J
Acetylcholinesterase activities in cerebrospinal fluid of patients with senile dementia of Alzheimer type.
Acta neurologica Scandinavica 1981;64(3):217-24.
-
1981: Soininen H; MacDonald E; Rekonen M; Riekkinen P J
Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with senile dementia of Alzheimer type.
Acta neurologica Scandinavica 1981;64(2):101-7.
-
1981: Danner R; Leino E; Partanen J; Riekkinen P J
Electrophysiological signs of peripheral nerve dysfunction in progressive myoclonus epilepsy.
Acta neurologica Scandinavica 1981;63(6):381-8.
-
1980: Partanen V S; Soininen H; Saksa M; Riekkinen P
Electromyographic and nerve conduction findings in a patient with neuromyotonia, normocalcemic tetany and small-cell lung cancer.
Acta neurologica Scandinavica 1980;61(4):216-26.
-
1973: Nevalainen T J; Panelius M; Riekkinen P J
Neuronal ceroid-lipofuscinosis. Report of two cases with neurochemical and morphological observations.
European neurology 1973;9(5):298-314.
Sign-in to see more